https://curecurrent.com/trials/the-effect-of-mifepristone-on-uterine-fibroids-and-breast-tissue-39001https://curecurrent.com/trials/veliparib-in-combination-with-carboplatin-and-paclitaxel-in-treating-patients-with-locally-advanced-or-metastatic-solid-39002https://curecurrent.com/trials/crossroad-ii-activating-rural-clinics-and-women-with-disabilities-to-improve-cancer-screening-39003https://curecurrent.com/trials/an-open-label-multi-center-expanded-access-program-with-eribulin-for-the-treatment-of-advanced-breast-cancer-refractory-39004https://curecurrent.com/trials/veliparib-carboplatin-and-paclitaxel-in-treating-patients-with-advanced-solid-cancer-39005https://curecurrent.com/trials/effect-of-morphine-tramadol-and-ketorolac-on-postoperative-stress-and-immune-responses-39006https://curecurrent.com/trials/randomized-phase-ii-trial-of-anastrozole-plus-metronomic-tegafur-uracil-as-neo-adjuvant-therapy-in-postmenopausal-breast-39007https://curecurrent.com/trials/oral-vinorelbine-in-combination-with-trastuzumab-for-metastatic-breast-cancer-39008https://curecurrent.com/trials/adjuvant-fec-versus-ep-in-breast-cancer-mig5-39009https://curecurrent.com/trials/epirubicin-and-docetaxel-combination-et-or-epirubicin-followed-by-docetaxel-e-t-for-node-negative-n0-high-risk-breast-ca-39010https://curecurrent.com/trials/oral-health-in-breast-cancer-survivors-on-aromatase-inhibitors-39011https://curecurrent.com/trials/comparison-of-diagnostic-performance-of-digital-breast-tomosynthesis-and-ultrasound-in-women-with-dense-breasts-39012https://curecurrent.com/trials/an-internet-based-weight-loss-and-exercise-intervention-for-breast-cancer-survivors-39013https://curecurrent.com/trials/effects-of-tamoxifen-in-premenopausal-women-with-benign-breast-disease-not-at-high-risk-of-developing-breast-cancer-39014https://curecurrent.com/trials/a-study-of-kx2-391-with-paclitaxel-in-patients-with-solid-tumors-39015https://curecurrent.com/trials/panitumumab-gemcitabine-and-carboplatin-in-triple-negative-metastatic-breast-cancer-39016https://curecurrent.com/trials/feasibility-and-efficacy-of-internet-delivered-cbt-for-insomnia-in-a-national-cohort-of-danish-breast-cancer-survivors-39017https://curecurrent.com/trials/patient-derived-breast-cancer-xenografts-39018https://curecurrent.com/trials/an-exercise-intervention-for-breast-cancer-patients-feasibility-and-effectiveness-beat-cancer-trial-pilot-study-39019https://curecurrent.com/trials/changes-in-cancer-related-cytokines-after-participation-in-a-physical-activity-behavior-change-intervention-cick-study-39020https://curecurrent.com/trials/an-observational-pilot-study-evaluating-the-feasibility-of-conducting-genome-wide-association-studies-utilizing-subject-39021https://curecurrent.com/trials/study-of-blood-samples-from-high-risk-postmenopausal-women-who-received-treatment-on-breast-cancer-prevention-clinical-t-39022https://curecurrent.com/trials/identification-of-genes-that-predict-local-recurrence-in-samples-from-patients-with-breast-cancer-treated-on-nsabp-b-28-39023https://curecurrent.com/trials/cancer-stem-cell-biomarkers-as-a-predictor-of-response-to-trastuzumab-in-samples-from-patients-with-breast-cancer-previo-39024https://curecurrent.com/trials/cisplatin-and-paclitaxel-with-or-without-everolimus-in-treating-patients-with-stage-ii-or-stage-iii-breast-cancer-39025https://curecurrent.com/trials/paclitaxel-with-without-gw572016-lapatinib-as-first-line-therapy-for-women-with-advanced-or-metastatic-breast-cancer-39026https://curecurrent.com/trials/phase-iii-study-comparing-the-efficacy-and-safety-of-ep2006-and-filgrastim-39027https://curecurrent.com/trials/inflammatory-response-and-tissue-fibrosis-lymphatico-venous-bypass-39028https://curecurrent.com/trials/combination-chemotherapy-plus-biological-therapy-in-treating-patients-with-stage-ii-or-stage-iii-breast-cancer-39029https://curecurrent.com/trials/phase-2-trial-of-cp-751-871-and-docetaxel-in-advanced-breast-cancer-39030https://curecurrent.com/trials/a-study-of-docetaxel-or-docetaxel-plus-pf-3512676-to-treat-patients-with-advanced-breast-cancer-39031https://curecurrent.com/trials/neoadjuvant-tipifarnib-docetaxel-and-capecitabine-in-treating-patients-with-locally-advanced-or-metastatic-solid-tumors-39032https://curecurrent.com/trials/intervention-study-of-depression-in-breast-cancer-patients-39033https://curecurrent.com/trials/safety-and-efficacy-study-of-the-trifunctional-antibody-ertumaxomab-to-treat-patients-with-advanced-or-metastatic-breast-39034https://curecurrent.com/trials/breast-cancer-survivorship-work-related-cognitive-limitation-39035https://curecurrent.com/trials/radiolabeled-monoclonal-antibody-followed-by-peripheral-stem-cell-transplantation-in-treating-patients-with-relapsed-or-39036https://curecurrent.com/trials/hospital-based-group-intervention-for-breast-cancer-patients-39037https://curecurrent.com/trials/acupuncture-in-treating-mucositis-related-pain-caused-by-chemotherapy-in-patients-undergoing-stem-cell-transplantation-39038https://curecurrent.com/trials/adjuvant-oophorectomy-and-tamoxifen-in-premenopausal-women-with-hormone-receptor-positive-breast-cancer-39039https://curecurrent.com/trials/lmb-9-immunotoxin-in-treating-patients-with-advanced-solid-tumors-39040https://curecurrent.com/trials/cellular-adoptive-immunotherapy-in-treating-a-patient-who-has-undergone-a-donor-stem-cell-transplant-for-breast-cancer-t-39041https://curecurrent.com/trials/lde225-in-treating-patients-with-stage-ii-iii-estrogen-receptor-and-her2-negative-breast-cancer-39042https://curecurrent.com/trials/comparing-the-efficacy-and-tolerability-of-fulvestrant-500-mg-versus-250-mg-in-advanced-breast-cancer-women-39043https://curecurrent.com/trials/primary-chemotherapy-with-anthracycline-followed-by-nab-paclitaxel-and-trastuzumab-39044https://curecurrent.com/trials/breast-cancer-recurrence-the-accuracy-of-dual-time-pet-ct-39045https://curecurrent.com/trials/diagosis-of-breast-carcinoma-characterization-of-breast-lesions-with-clearpemsonic-feasibility-study-39046https://curecurrent.com/trials/a-novel-prosocial-online-support-group-for-distressed-breast-cancer-survivors-39047https://curecurrent.com/trials/ro4929097-and-vismodegib-in-treating-patients-with-breast-cancer-that-is-metastatic-or-cannot-be-removed-by-surgery-39048https://curecurrent.com/trials/targeting-the-hippo-transducer-taz-in-breast-cancer-with-statins-39049https://curecurrent.com/trials/anastrozole-plus-lonafarnib-sch-66336-or-plus-placebo-for-the-treatment-of-advanced-breast-cancer-p03480-39050https://curecurrent.com/trials/oral-drug-study-in-women-with-refractory-metastatic-breast-cancer-after-first-line-or-second-line-herceptin-39051https://curecurrent.com/trials/the-sister-study-genetic-and-environmental-risk-factors-for-breast-cancer-39052https://curecurrent.com/trials/gw572016-for-treatment-of-refractory-metastatic-breast-cancer-39053https://curecurrent.com/trials/physician-liver-function-test-lft-monitoring-for-tykerb-pts-39054https://curecurrent.com/trials/a-yoga-and-wellness-program-for-breast-cancer-survivors-with-persistent-fatigue-39055https://curecurrent.com/trials/the-effectiveness-of-mindfulness-on-chronic-pain-in-breast-cancer-survivors-39056https://curecurrent.com/trials/the-role-of-serotonin-in-hot-flashes-after-breast-cancer-39057https://curecurrent.com/trials/photography-or-video-in-assessing-breast-reconstruction-39058https://curecurrent.com/trials/a-home-based-physical-activity-intervention-in-breast-cancer-survivors-39059https://curecurrent.com/trials/early-detection-of-lymphedema-after-cancer-treatments-39060https://curecurrent.com/trials/investigation-of-sex-hormone-levels-in-chinese-women-with-invasive-breast-cancer-39061https://curecurrent.com/trials/evaluate-the-use-of-paravertebral-block-in-reconstructive-breast-surgery-39062https://curecurrent.com/trials/single-versus-double-drains-after-mastectomy-39063https://curecurrent.com/trials/effect-of-weight-loss-on-breast-density-using-digital-mammography-and-mri-in-women-who-are-at-increased-risk-for-breast-39064https://curecurrent.com/trials/cognitive-rehabilitation-group-intervention-for-breast-cancer-survivors-39065https://curecurrent.com/trials/a-mindfulness-meditation-based-intervention-for-younger-breast-cancer-survivors-39066https://curecurrent.com/trials/axillary-reverse-mapping-for-breast-carcinomas-39067https://curecurrent.com/trials/single-vs-double-drain-in-modified-radical-mastectomy-39068https://curecurrent.com/trials/the-effect-of-meditation-and-massage-therapy-for-breast-cancer-patients-undergoing-tissue-reconstruction-39069https://curecurrent.com/trials/rebecca-study-radiotherapy-for-breast-cancer-and-cardiotoxicity-39070https://curecurrent.com/trials/brown-seaweed-as-a-breast-cancer-preventive-39071https://curecurrent.com/trials/goserelin-and-letrozole-or-anastrozole-in-premenopausal-patients-with-stage-ii-iii-estrogen-receptor-positive-breast-can-39072https://curecurrent.com/trials/effectivenes-of-cyanoacrylate-glubran-2-in-reducing-seroma-formation-in-breast-cancer-patients-post-axillary-dissection-39073https://curecurrent.com/trials/behavioral-intervention-study-for-better-breast-and-cervical-cancer-control-for-korean-american-women-39074https://curecurrent.com/trials/medical-radiometer-rtm-01-res-and-its-use-in-detecting-hotspots-in-female-breast-39075https://curecurrent.com/trials/feasibility-study-of-stereotactic-body-radiotherapy-for-early-breast-cancer-39076https://curecurrent.com/trials/trial-comparing-perioperative-care-for-breast-cancer-patients-at-a-patient-hotel-vs-a-general-surgical-ward-39077https://curecurrent.com/trials/breast-cancer-margin-delineation-using-polarization-subtraction-imaging-technology-39078https://curecurrent.com/trials/abc-survey-do-we-meet-the-needs-of-patients-with-advanced-breast-cancer-39079https://curecurrent.com/trials/randomized-phase-ii-trial-induction-therapy-for-early-stage-breast-cancer-39080https://curecurrent.com/trials/predictive-model-of-therapy-outcomes-in-breast-cancer-patients-39081https://curecurrent.com/trials/partial-breast-radiation-therapy-in-treating-women-with-early-stage-breast-cancer-39082https://curecurrent.com/trials/pazopanib-in-treating-patients-with-newly-diagnosed-or-locally-and-or-regionally-recurrent-breast-cancer-that-can-be-rem-39083https://curecurrent.com/trials/flexitouch-lymphedema-system-in-treating-stage-ii-lymphedema-in-patients-with-breast-cancer-39084https://curecurrent.com/trials/surgical-metabolic-phenotyping-longitudinal-evaluation-study-39085https://curecurrent.com/trials/sense-of-hope-alleviates-fatigue-in-breast-cancer-survivors-39086https://curecurrent.com/trials/cytoxan-epirubicin-and-capecitabine-in-women-with-breast-cancer-39087https://curecurrent.com/trials/phase-i-study-of-dasatinib-bms-354825-and-capecitabine-for-women-with-advanced-breast-cancer-39088https://curecurrent.com/trials/phase-ii-study-using-genomic-proteomic-profiling-to-influence-treatments-for-patients-with-metastatic-breast-cancer-39089https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-irosustat-when-added-to-an-ai-in-er-ve-locally-advanced-or-metastatic-breast-39090https://curecurrent.com/trials/melatonin-versus-placebo-in-breast-cancer-39091https://curecurrent.com/trials/gemcitabine-plus-cisplatin-versus-gemcitabine-plus-paclitaxel-in-triple-negative-breast-cancer-tnbc-39092https://curecurrent.com/trials/a-prospective-observational-study-of-clinical-outcomes-for-the-nanostring-technologies-prosigna-gene-signature-assay-39093https://curecurrent.com/trials/outpatient-health-care-program-for-older-patients-receiving-chemotherapy-for-newly-diagnosed-breast-cancer-or-colon-canc-39094https://curecurrent.com/trials/suberoylanilide-hydroxamic-acid-in-treating-patients-with-progressive-stage-iv-breast-cancer-39095https://curecurrent.com/trials/dual-energy-contrast-enhanced-2d-and-3d-mammography-versus-contrast-enhanced-mri-a-pilot-study-39096https://curecurrent.com/trials/tumor-suppressor-status-as-a-predictor-of-chemotherapy-response-in-triple-negative-breast-cancer-39097https://curecurrent.com/trials/suramin-and-paclitaxel-in-treating-women-with-stage-iiib-iv-breast-cancer-39098https://curecurrent.com/trials/a-study-of-v934-v935-vaccine-in-cancer-participants-with-selected-solid-tumors-v934-002-39099https://curecurrent.com/trials/intra-operative-radiotherapy-for-breast-cancer-women-after-nsm-39100https://curecurrent.com/trials/intra-operative-radiotherapy-for-women-with-ductal-carcinoma-in-situ-breast-cancer-39101https://curecurrent.com/trials/comparison-of-intra-operative-radiotherapy-with-post-operative-radiotherapy-for-women-with-ductal-carcinoma-in-situ-39102https://curecurrent.com/trials/a-study-of-herceptin-trastuzumab-in-combination-chemotherapy-in-patients-with-metastatic-or-locally-advanced-breast-canc-39103https://curecurrent.com/trials/pma-required-pivotal-multi-reader-multi-case-reader-study-39104https://curecurrent.com/trials/blood-oxygen-level-dependent-magnetic-resonance-imaging-bold-mri-and-fluorothymidine-positron-emission-tomography-flt-pe-39105https://curecurrent.com/trials/cp-751871-in-treating-women-with-early-stage-breast-cancer-that-can-be-removed-by-surgery-39106https://curecurrent.com/trials/study-of-imf-001-in-patients-with-malignancies-expressing-ny-eso-1-39107https://curecurrent.com/trials/investigating-the-impact-of-tamoxifen-therapy-on-ovarian-aging-39108https://curecurrent.com/trials/neoadjuvant-chemotherapy-including-sorafenib-in-women-with-previously-untreated-primary-breast-cancer-39109https://curecurrent.com/trials/comparing-sis-net-to-standard-care-in-patients-who-have-completed-the-acute-phase-of-treatment-for-early-breast-cancer-39110https://curecurrent.com/trials/savi-scout-clinical-evaluation-study-39111https://curecurrent.com/trials/evaluation-of-specific-biomarkers-in-primary-invasive-breast-cancer-39112https://curecurrent.com/trials/the-synergism-or-long-duration-sold-study-39113https://curecurrent.com/trials/docetaxel-and-cisplatin-chemotherapy-with-or-without-high-dose-proton-pump-inhibitor-in-metastatic-breast-cancer-39114https://curecurrent.com/trials/glowcap-reminder-system-in-patients-with-early-stage-breast-cancer-receiving-adjuvant-endocrine-therapy-39115https://curecurrent.com/trials/postoperative-use-of-zoledronic-acid-in-breast-cancer-patients-after-neoadjuvant-chemotherapy-39116https://curecurrent.com/trials/hydralazine-as-demethylating-agent-in-breast-cancer-39117https://curecurrent.com/trials/histologic-diagnoses-of-incidentally-detected-lesions-on-mri-39118https://curecurrent.com/trials/use-of-breast-mri-for-local-staging-39119https://curecurrent.com/trials/six-vs-12-months-of-trastuzumab-with-docetaxel-following-fec-as-adjuvant-treatment-in-n-breast-cancer-39120https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-xeloda-capecitabine-as-maintenance-therapy-in-patients-with-her2-negative-metastatic-brea-39121https://curecurrent.com/trials/role-of-surgery-for-the-primary-in-patients-with-breast-cancer-stage-iv-39122https://curecurrent.com/trials/hand-in-hand-psychological-support-and-counseling-to-breast-cancer-patients-and-their-partners-39123https://curecurrent.com/trials/dose-escalation-study-of-i-131-clr1404-in-subjects-with-cancer-that-does-not-respond-to-treatment-or-has-returned-39124https://curecurrent.com/trials/the-evaluation-of-the-efficacy-and-tolerability-of-faslodex-fulvestrant-and-aromasin-exemestane-in-hormone-receptor-posi-39125https://curecurrent.com/trials/phase-ii-study-of-capecitabine-and-cisplatin-to-treat-metastatic-triple-negative-breast-cancer-39126https://curecurrent.com/trials/study-of-cr011-vcmmae-to-treat-locally-advanced-or-metastatic-breast-cancer-39127https://curecurrent.com/trials/phase-ii-study-with-abraxane-bevacizumab-and-carboplatin-in-triple-negative-metastatic-breast-cancer-39128https://curecurrent.com/trials/life-quality-and-mental-state-in-patients-with-breast-cancer-39129https://curecurrent.com/trials/study-of-physiological-and-high-dose-estradiol-in-the-treatment-of-hormone-receptor-positive-metastatic-breast-cancer-39130https://curecurrent.com/trials/a-study-of-nk012-in-patients-with-advanced-metastatic-triple-negative-breast-cancer-39131https://curecurrent.com/trials/metabolic-changes-as-a-diagnostic-indicator-for-cancer-39132https://curecurrent.com/trials/sentinel-node-biopsy-following-neoadjuvant-chemotherapy-in-biopsy-proven-node-positive-breast-cancer-39133https://curecurrent.com/trials/study-evaluating-impact-of-il-7-on-cd4-lymphopenia-risks-of-severe-haematological-toxicity-and-tumor-progression-in-meta-39134https://curecurrent.com/trials/study-of-impact-of-routine-clinical-cancer-department-supportive-care-department-consultation-on-the-prescription-of-an-39135https://curecurrent.com/trials/evaluation-of-magnetic-resonance-imaging-mri-vs-molecular-breast-imaging-tc-mbi-in-breast-cancer-patients-39136https://curecurrent.com/trials/physician-patient-communication-about-breast-cancer-related-internet-information-and-its-effect-on-patient-satisfaction-39137https://curecurrent.com/trials/cryotherapy-for-breast-cancer-trial-39138https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-activity-of-lonafarnib-and-docetaxel-study-p04467am1-terminated-39139https://curecurrent.com/trials/rna-disruption-assay-rda-response-prediction-in-neoadjuvant-chemotherapy-breast-cancer-treatment-39140https://curecurrent.com/trials/breast-sparing-proton-therapy-for-hodgkin-s-disease-39141https://curecurrent.com/trials/impact-of-breast-magnetic-resonance-imaging-mri-on-mastectomy-rates-39142https://curecurrent.com/trials/ar-inhibitor-bicalutamide-in-treating-patients-with-tnbc-39143https://curecurrent.com/trials/trial-of-fulvestrant-mk-0646-and-dasatinib-for-metastatic-hormone-receptor-positive-her2-negative-breast-cancer-39144https://curecurrent.com/trials/effects-of-a-dexmedetomidine-on-quality-of-recovery-40-and-postoperative-nausea-and-vomiting-in-breast-cancer-surgery-39145https://curecurrent.com/trials/a-notch-signalling-pathway-inhibitor-for-patients-with-advanced-breast-cancer-0752-014-39146https://curecurrent.com/trials/ultrasound-guided-pectoral-nerves-blockade-for-persistent-pain-after-breast-cancer-surgery-39147https://curecurrent.com/trials/re-expression-of-er-in-triple-negative-breast-cancers-39148https://curecurrent.com/trials/study-adding-multikinase-inhibitor-sorafenib-to-existing-endocrine-therapy-in-patients-with-advanced-breast-cancer-39149https://curecurrent.com/trials/an-open-label-phase-i-iia-dose-escalating-study-of-2b3-101-in-patients-with-solid-tumors-and-brain-metastases-or-recurre-39150https://curecurrent.com/trials/the-growth-factor-signature-gfs-as-an-intermediate-biomarker-of-response-for-development-of-pi3k-pathway-inhibitors-in-p-39151https://curecurrent.com/trials/safety-study-of-vm206ry-in-subjects-with-expression-of-her2-in-breast-cancer-39152https://curecurrent.com/trials/cultured-circulating-tumor-cells-in-prostate-and-other-cancers-39153https://curecurrent.com/trials/bromelain-comosain-as-a-new-drug-for-treating-and-preventing-various-types-of-cancer-in-the-humans-39154https://curecurrent.com/trials/an-online-enhanced-education-tool-for-young-women-newly-diagnosed-with-breast-cancer-39155https://curecurrent.com/trials/alberta-physical-activity-and-breast-cancer-prevention-alpha-trial-39156https://curecurrent.com/trials/feasibility-study-on-stem-cells-sensitivity-assay-39157https://curecurrent.com/trials/phase-i-study-of-mt110-in-lung-cancer-adenocarcinoma-and-small-cell-gastric-cancer-or-adenocarcinoma-of-the-gastro-esoph-39158https://curecurrent.com/trials/colombian-screening-mammography-project-39159https://curecurrent.com/trials/pet-study-of-breast-cancer-patients-using-68ga-aby-025-39160https://curecurrent.com/trials/a-study-of-mm-111-in-patients-with-advanced-refractory-her2-amplified-heregulin-positive-cancers-39161https://curecurrent.com/trials/tipifarnib-and-gemcitabine-hydrochloride-in-treating-women-with-metastatic-breast-cancer-39162https://curecurrent.com/trials/internet-delivered-cognitive-training-for-breast-cancer-survivors-with-cognitive-complaints-39163https://curecurrent.com/trials/investigation-of-stem-cells-in-human-lipoaspirate-39164https://curecurrent.com/trials/neuropathic-pain-in-survivors-of-breast-cancer-39165https://curecurrent.com/trials/incorporation-of-allomaxtm-in-breast-reconstruction-ver8-15-12-39166https://curecurrent.com/trials/melatonin-as-adjuvant-therapy-in-breast-cancer-patients-39167https://curecurrent.com/trials/study-to-evaluate-combination-treatment-of-mgcd0103-and-docetaxel-taxotere-for-subjects-with-advanced-cancer-tumors-39168https://curecurrent.com/trials/fluorescent-dyes-for-lymph-node-mapping-39169https://curecurrent.com/trials/mm-111-in-combination-with-herceptin-in-patients-with-advanced-her2-amplified-heregulin-positive-breast-cancer-39170https://curecurrent.com/trials/risk-factors-for-skeletal-related-events-in-breast-cancer-patients-receiving-bisphosphonates-for-bone-metastases-39171https://curecurrent.com/trials/effectiveness-of-reduced-gcsf-dosing-in-patients-with-a-low-to-moderate-risk-of-febrile-neutropenia-39172https://curecurrent.com/trials/computed-optical-margin-assessment-for-breast-cancer-surgery-phase-i-part-a-39173https://curecurrent.com/trials/fragrance-part-a-safety-study-to-find-a-genetic-signature-of-de-novo-resistance-to-letrozole-39174https://curecurrent.com/trials/mammaglobin-a-dna-vaccine-for-metastatic-breast-cancer-39175https://curecurrent.com/trials/cady-study-icorg-08-01-39176https://curecurrent.com/trials/triple-negative-breast-cancer-study-of-molecular-and-genetic-factors-39177https://curecurrent.com/trials/lapatinib-and-wbrt-for-patients-with-brain-metastases-from-lung-or-breast-tumors-39178https://curecurrent.com/trials/gadobutrol-magnevist-controlled-body-study-39179https://curecurrent.com/trials/68ga-nota-nfb-radiation-dosimetry-in-healthy-volunteers-and-applications-in-glioma-patients-or-breast-cancer-patients-39180https://curecurrent.com/trials/evaluation-of-continuous-positive-airway-pressure-for-tumor-motion-management-in-radiotherapy-39181https://curecurrent.com/trials/clinical-trial-of-quantitative-detection-kit-for-hsp90-in-breast-cancer-39182https://curecurrent.com/trials/gamma-secretase-inhibitor-ro4929097-and-cediranib-maleate-in-treating-patients-with-advanced-solid-tumors-39183https://curecurrent.com/trials/evaluation-of-bay59-8862-in-taxane-resistant-metastatic-breast-cancer-patients-39184https://curecurrent.com/trials/uterine-cavity-assessment-and-endometrial-gene-expression-in-tamoxifen-treated-breast-cancer-patients-39185https://curecurrent.com/trials/partial-breast-irradiation-with-interstitial-high-dose-rate-brachytherapy-39186https://curecurrent.com/trials/trial-of-paclitaxel-bevacizumab-everolimus-for-patients-with-her2-negative-metastatic-breast-cancer-39187https://curecurrent.com/trials/phase-i-ii-trial-of-sorafenib-plus-ixabepilone-in-her2-negative-metastatic-breast-cancer-39188https://curecurrent.com/trials/neoadjuvant-ixabepilone-carboplatin-trastuzumab-in-her2-positive-locally-advanced-breast-cancer-39189https://curecurrent.com/trials/safety-and-efficacy-study-of-vintafolide-and-vintafolide-plus-paclitaxel-compared-to-paclitaxel-alone-in-participants-wi-39190https://curecurrent.com/trials/participation-restrictions-in-breast-cancer-survivors-39191https://curecurrent.com/trials/trial-of-drain-antisepsis-after-tissue-expander-breast-reconstruction-39192https://curecurrent.com/trials/early-intervention-vs-standard-palliative-care-in-improving-end-of-life-care-in-advanced-cancer-patients-39193https://curecurrent.com/trials/fec-with-g-csf-support-followed-by-ixabepilone-with-g-csf-support-as-neoadjuvant-chemotherapy-in-bc-39194https://curecurrent.com/trials/a-study-of-herceptin-trastuzumab-in-combination-with-xeloda-capecitabine-in-patients-with-metastatic-or-recurrent-her2-p-39195https://curecurrent.com/trials/examining-a-common-complaint-of-women-who-receive-chemotherapy-for-breast-cancer-cognitive-difficulty-39196https://curecurrent.com/trials/positron-emission-tomography-using-3-deoxy-3-18f-fluorothymidine-in-treating-women-with-locally-advanced-cancer-in-one-b-39197https://curecurrent.com/trials/evaluating-lapatinib-capecitabine-in-patients-aged-70-and-over-with-her2-metastatic-breast-cancer-39198https://curecurrent.com/trials/combination-chemotherapy-compared-with-observation-after-surgery-in-treating-women-with-relapsed-nonmetastatic-breast-ca-39199https://curecurrent.com/trials/high-dose-chemotherapy-plus-peripheral-stem-cell-transplantation-compared-with-standard-therapy-in-treating-women-with-l-39200https://curecurrent.com/trials/study-of-abraxane-and-carboplatin-as-first-line-treatment-for-triple-negative-metastatic-breast-cancer-39201https://curecurrent.com/trials/evaluation-of-a-new-radiotracer-64cu-dota-ae105-for-diagnosing-aggressive-cancer-with-positron-emission-tomography-39202https://curecurrent.com/trials/gentamicin-versus-clindamycin-versus-normal-saline-lavage-in-axilla-39203https://curecurrent.com/trials/an-interactive-empowerment-tool-for-breast-cancer-patients-39204https://curecurrent.com/trials/caelyx-adjuvant-in-elderly-breast-cancer-39205https://curecurrent.com/trials/gene-polymorphisms-and-gene-products-as-biological-markers-of-aging-and-correlation-with-clinical-geriatric-assessment-t-39206https://curecurrent.com/trials/assessment-of-cellular-proliferation-in-tumors-by-positron-emission-tomography-pet-using-18f-iso-1-39207https://curecurrent.com/trials/electrochemotherapy-for-the-treatment-of-breast-cancer-that-has-spread-to-the-skin-39208https://curecurrent.com/trials/trial-exploring-feasibility-of-densification-and-optimal-sequencing-of-postoperative-adjuvant-fluorouracil-epirubicin-pl-39209https://curecurrent.com/trials/everolimus-trial-for-advanced-prememopausal-breast-cancer-patients-39210https://curecurrent.com/trials/paclitaxel-and-bkm120-before-surgery-in-treating-patients-with-stage-ii-or-iii-estrogen-receptor-positive-and-her2-negat-39211https://curecurrent.com/trials/comparison-of-intra-operative-radiotherapy-with-post-operative-radiotherapy-for-women-with-early-breast-cancer-39212https://curecurrent.com/trials/genetikit-evaluation-of-an-educational-intervention-on-the-delivery-of-genetics-services-by-family-physicians-39213https://curecurrent.com/trials/phase-ii-study-with-trastuzumab-paclitaxel-in-locally-advanced-her2-tumors-or-epirubicin-taxotere-in-her2-tumors-39214https://curecurrent.com/trials/laser-therapy-for-the-management-of-radiation-dermatitis-39215https://curecurrent.com/trials/menopause-and-meditation-for-breast-cancer-survivors-39216https://curecurrent.com/trials/behavioral-weight-loss-and-exercise-after-treatment-beat-39217https://curecurrent.com/trials/safety-and-efficacy-study-of-a-new-chemotherapy-agent-to-treat-metastatic-breast-cancer-39218https://curecurrent.com/trials/polymorphism-interaction-to-predict-bevacizumab-efficacy-39219https://curecurrent.com/trials/evaluating-the-effect-of-candesartan-vs-placebo-in-prevention-of-trastuzumab-associated-cardiotoxicity-39220https://curecurrent.com/trials/additional-4-cycles-of-cisplatin-cddp4-in-patients-with-triple-negative-breast-cancer-for-neoadjuvant-chemotherapy-39221https://curecurrent.com/trials/a-telephone-based-prevention-care-manager-in-increasing-screening-rates-for-breast-cancer-cervical-cancer-and-colorectal-39222https://curecurrent.com/trials/exercise-in-breast-cancer-survivors-39223https://curecurrent.com/trials/a-clinical-study-to-evaluate-somo-v-and-digital-mammography-together-as-a-breast-cancer-screening-method-compared-to-dig-39224https://curecurrent.com/trials/a-study-of-zoledronic-acid-in-the-prevention-of-cancer-therapy-induced-bone-loss-39225https://curecurrent.com/trials/study-of-optimizing-neoadjuvant-regimens-in-subtypes-of-breast-cancer-39226https://curecurrent.com/trials/a-study-of-adoptive-immunotherapy-with-autologous-tumor-infiltrating-lymphocytes-in-solid-tumors-39227https://curecurrent.com/trials/cognitive-enhancement-program-in-improving-cognitive-function-in-breast-cancer-survivors-39228https://curecurrent.com/trials/dose-finding-study-for-combination-of-capecitabine-lapatinib-and-vinorelbine-in-metastatic-breast-cancer-39229https://curecurrent.com/trials/phase-ii-trial-of-saha-tamoxifen-for-patients-with-breast-cancer-39230https://curecurrent.com/trials/randomized-boost-versus-no-boost-irradiation-of-early-breast-cancer-39231https://curecurrent.com/trials/long-term-active-surveillance-study-for-oral-contraceptives-lass-39232https://curecurrent.com/trials/sentinel-lymph-node-total-tumoral-load-as-a-predictor-of-non-sentinel-node-involvement-in-early-breast-cancer-39233https://curecurrent.com/trials/phase-ii-neoadjuvant-in-inflammatory-breast-cancer-39234https://curecurrent.com/trials/safety-study-of-multiple-vaccine-to-treat-metastatic-breast-cancer-39235https://curecurrent.com/trials/prospective-pilot-study-andprecise-39236https://curecurrent.com/trials/metronomic-chemotherapy-of-capecitabine-after-standard-adjuvant-chemotherapy-in-operable-triple-negative-breast-cancer-39237https://curecurrent.com/trials/study-of-nk012-and-carboplatin-in-solid-tumors-with-dose-expansion-in-triple-negative-breast-cancer-39238https://curecurrent.com/trials/efficacy-and-safety-of-gadobutrol-1-0-molar-gadovist-for-breast-mri-39239https://curecurrent.com/trials/cyclophosphamide-or-denileukin-diftitox-followed-by-expanding-a-patient-s-own-t-cells-in-the-laboratory-in-treating-pati-39240https://curecurrent.com/trials/efficacy-and-safety-of-gadobutrol-1-0-molar-gadovist-for-breast-magnetic-resonance-imaging-mri-39241https://curecurrent.com/trials/a-phase-i-study-of-lfa102-in-japanese-patients-39242https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-and-sequential-chemotherapy-in-patients-with-primary-her2-negative-operable-breast-cancer-39243https://curecurrent.com/trials/whole-breast-rt-on-prone-position-in-korean-women-39244https://curecurrent.com/trials/ro4929097-and-capecitabine-in-treating-patients-with-refractory-solid-tumors-39245https://curecurrent.com/trials/induction-preoperative-chemotherapy-for-patients-with-locally-advanced-triple-negative-breast-cancer-39246https://curecurrent.com/trials/cardiotoxicity-of-adjuvant-trastuzumab-39247https://curecurrent.com/trials/a-study-to-evaluate-safety-and-tolerability-in-patients-with-metastatic-breast-cancer-receiving-treatment-with-caelyx-st-39248https://curecurrent.com/trials/metabolic-syndrome-and-female-breast-cancer-39249https://curecurrent.com/trials/gti-2040-and-capecitabine-in-treating-patients-with-metastatic-breast-cancer-39250https://curecurrent.com/trials/impact-of-nutritional-intervention-in-women-with-breast-cancer-under-adjuvant-chemotherapy-39251https://curecurrent.com/trials/doxorubicin-hydrochloride-liposome-as-first-line-therapy-in-treating-older-women-with-metastatic-breast-cancer-39252https://curecurrent.com/trials/a-study-of-herceptin-trastuzumab-in-combination-chemotherapy-in-women-with-locally-advanced-breast-cancer-39253https://curecurrent.com/trials/thor-study-a-study-of-continued-herceptin-trastuzumab-in-combination-with-second-line-chemotherapy-in-patients-with-her2-39254https://curecurrent.com/trials/18-f-fluoroacetate-as-pet-imaging-agent-39255https://curecurrent.com/trials/akt-inhibitor-mk2206-in-combination-with-lapatinib-ditosylate-in-patients-with-advanced-or-metastatic-solid-tumors-or-br-39256https://curecurrent.com/trials/prevention-of-cardiac-dysfunction-during-adjuvant-breast-cancer-therapy-39257https://curecurrent.com/trials/redes-ii-national-patient-navigator-intervention-study-39258https://curecurrent.com/trials/ultrasound-based-breast-cancer-screening-in-chinese-women-39259https://curecurrent.com/trials/letrozole-in-preventing-breast-cancer-in-healthy-postmenopausal-women-at-high-risk-for-breast-cancer-39260https://curecurrent.com/trials/phase-i-at-home-support-for-rural-women-using-group-video-calling-39261https://curecurrent.com/trials/effect-of-concomitant-radiotherapy-and-trastuzumab-on-cardiotoxicity-of-patients-treated-for-early-breast-cancer-39262https://curecurrent.com/trials/icg-distribution-using-nif-imaging-after-iv-injection-of-icg-in-benign-and-malignant-breast-cancer-tissue-39263https://curecurrent.com/trials/magnetic-resonance-thermal-image-guided-laser-interstitial-thermal-therapy-in-treating-patients-with-breast-cancer-39264https://curecurrent.com/trials/big-molecular-screening-feasibility-study-39265https://curecurrent.com/trials/study-of-preoperative-weekly-paclitaxel-and-carboplatin-with-lapatinib-tykerb-in-patients-with-erbb2-positive-stage-i-ii-39266https://curecurrent.com/trials/trial-of-dasatinib-plus-ixabepilone-in-2nd-or-3rd-line-metastatic-breast-cancer-39267https://curecurrent.com/trials/zk-230211-in-postmenopausal-woman-with-metastatic-breast-cancer-39268https://curecurrent.com/trials/faslodex-post-marketing-surveillance-39269https://curecurrent.com/trials/to-compare-treatment-with-doxorubicin-or-capecitabine-for-metastatic-breast-cancer-in-women-60-years-and-older-39270https://curecurrent.com/trials/a-pilot-study-of-irinotecan-in-patients-with-breast-cancer-and-cns-metastases-39271https://curecurrent.com/trials/phase-2-study-of-fulvestrant-with-and-without-entinostat-in-postmenopausal-women-with-er-advanced-breast-cancer-39272https://curecurrent.com/trials/effect-of-midazolam-premedication-before-induction-on-the-functional-recovery-after-general-anesthesia-in-the-patients-u-39273https://curecurrent.com/trials/phase-i-ii-study-of-lapatinib-in-combination-with-paclitaxel-as-1l-chemotherapy-for-erbb2-positive-mbc-39274https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-t-dm1-sequentially-with-anthracycline-based-chemotherapy-as-adjuvant-or-neoadjuvant-the-39275https://curecurrent.com/trials/population-based-patient-centric-care-comprehensive-preventive-cancer-screening-using-health-it-39276https://curecurrent.com/trials/alpha-lipoic-acid-in-patients-at-risk-for-paclitaxel-induced-neuropathy-39277https://curecurrent.com/trials/a-study-of-genetic-based-chemotherapy-dosing-for-breast-cancer-patients-39278https://curecurrent.com/trials/breast-lesions-characterization-on-contrast-enhanced-ultrasound-with-histopathological-correlation-39279https://curecurrent.com/trials/breast-cancer-treated-by-neoadjuvant-chemotherapy-39280https://curecurrent.com/trials/sentinel-lymph-node-biopsy-with-superparamagnetic-iron-oxide-for-breast-cancer-patients-after-neoadjuvant-treatment-39281https://curecurrent.com/trials/a-study-of-subcutaneously-administered-herceptin-trastuzumab-in-patients-with-human-epidermal-growth-factor-receptor-2-h-39282https://curecurrent.com/trials/alopecia-secondary-to-endocrine-therapy-in-postmenopausal-women-with-breast-cancer-39283https://curecurrent.com/trials/calcium-and-magnesium-infusion-for-the-prevention-of-taxane-induced-neuropathy-39284https://curecurrent.com/trials/a-study-of-lapatinib-in-combination-with-everolimus-in-patients-with-advanced-triple-negative-breast-cancer-39285https://curecurrent.com/trials/a-pilot-study-of-vegf-inhibition-in-patients-with-lymphedema-following-breast-cancer-treatment-39286https://curecurrent.com/trials/high-dose-vit-d-musculoskeletal-symptoms-bone-density-in-anastrozole-treated-breast-cancer-with-marginal-vit-d-status-39287https://curecurrent.com/trials/brain-mets-capecitabine-plus-sunitinib-and-wbrt-39288https://curecurrent.com/trials/effect-of-yoga-on-life-quality-and-immunity-in-breast-cancer-patients-after-operation-and-or-chemotherapy-39289https://curecurrent.com/trials/effects-of-controlled-ovarian-hyperstimulation-coh-with-letrozole-and-gonadotropin-39290https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-who-are-undergoing-surgery-for-ductal-carcinoma-in-situ-of-the-breast-39291https://curecurrent.com/trials/letrozole-herceptin-in-her2neu-estrogen-receptor-er-and-or-progesterone-receptor-pr-positive-mbc-39292https://curecurrent.com/trials/a-study-of-herceptin-trastuzumab-in-women-with-metastatic-breast-cancer-39293https://curecurrent.com/trials/defined-green-tea-catechin-extract-in-treating-women-with-hormone-receptor-negative-stage-i-iii-breast-cancer-39294https://curecurrent.com/trials/interleukin-12-in-treating-patients-with-hematologic-cancers-or-solid-tumors-39295https://curecurrent.com/trials/preoperative-oral-dexamethasone-to-improve-recovery-after-surgery-39296https://curecurrent.com/trials/the-impact-of-a-patient-education-intervention-for-ambulatory-oncology-patients-39297https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-advanced-or-metastatic-cancer-39298https://curecurrent.com/trials/a-structured-walking-program-or-standard-therapy-in-cancer-patients-undergoing-a-donor-bone-marrow-transplant-39299https://curecurrent.com/trials/a-clinical-trial-comparing-gemcitabine-and-carboplatin-with-and-without-p276-00-in-subjects-with-metastatic-triple-negat-39300https://curecurrent.com/trials/therapy-of-metastatic-breast-cancer-with-paclitaxel-and-liposomal-doxorubicin-39301https://curecurrent.com/trials/pegylated-liposomal-doxorubicin-and-docetaxel-in-treating-women-with-locally-advanced-breast-cancer-that-can-be-removed-39302https://curecurrent.com/trials/nurse-led-care-program-for-cancer-patients-in-chemotherapy-day-center-39303https://curecurrent.com/trials/weekly-paclitaxel-liposome-injection-plus-cisplatin-in-preoperative-treatment-of-breast-cancer-39304https://curecurrent.com/trials/a-phase-ii-study-of-dose-density-regimen-with-fluorouracil-epirubicin-and-cyclophosphamide-at-days-1-4-every-14-days-wit-39305https://curecurrent.com/trials/lymphedema-prevention-in-breast-cancer-39306https://curecurrent.com/trials/mbi-and-breast-tomosynthesis-screening-accuracies-in-patients-with-dense-breast-tissue-39307https://curecurrent.com/trials/continued-efficacy-and-safety-of-zoledronic-acid-q-4-wks-vs-q-12-wks-in-the-2nd-year-of-treatment-in-patients-with-bone-39308https://curecurrent.com/trials/low-dose-molecular-breast-imaging-as-a-screening-tool-for-women-with-dense-breasts-39309https://curecurrent.com/trials/breast-cancer-risk-reduction-a-patient-doctor-intervention-39310https://curecurrent.com/trials/octavapink-for-women-with-dense-breast-after-negative-mammography-39311https://curecurrent.com/trials/tykerb-evaluation-after-chemotherapy-teach-lapatinib-versus-placebo-in-women-with-early-stage-breast-cancer-39312https://curecurrent.com/trials/comparison-of-neo-adjuvant-weekly-paclitaxel-with-or-without-carboplatin-in-early-breast-cancer-39313https://curecurrent.com/trials/accelerated-partial-breast-irradiation-with-3d-crt-and-imrt-39314https://curecurrent.com/trials/pre-operative-study-of-pf-4691502-with-letrozole-compared-to-letrozole-alone-in-patients-with-early-breast-cancer-39315https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-xeloda-capecitabine-and-docetaxel-in-patients-with-inflammatory-or-lo-39316https://curecurrent.com/trials/a-study-of-herceptin-trastuzumab-in-combination-with-whole-brain-radiotherapy-in-patients-with-her-2-positive-breast-can-39317https://curecurrent.com/trials/role-of-beta-endorphin-in-cancer-therapy-fatigue-39318https://curecurrent.com/trials/contrast-enhanced-mr-imaging-as-a-breast-cancer-screening-in-women-at-intermediate-risk-39319https://curecurrent.com/trials/digital-3d-breast-tomosynthesis-versus-2d-in-clinical-evaluation-of-high-risk-women-39320https://curecurrent.com/trials/molecular-breast-imaging-as-a-screening-tool-for-women-with-dense-breasts-39321https://curecurrent.com/trials/sentinel-and-or-axillary-lymph-node-biopsy-with-or-without-axillary-reverse-mapping-in-reducing-incidence-and-severity-o-39322https://curecurrent.com/trials/lynne-cohen-consortium-project-multi-center-database-registry-39323https://curecurrent.com/trials/effects-of-yoga-on-menopausal-symptoms-in-women-with-breast-cancer-39324https://curecurrent.com/trials/a-phase-1-open-label-dose-escalation-study-of-ang1005-in-patients-with-advanced-solid-tumors-and-metastatic-brain-cancer-39325https://curecurrent.com/trials/biodistribution-study-with-186-re-labelled-humanised-monoclonal-antibody-biwa-4-in-patients-with-adenocarcinoma-of-the-b-39326https://curecurrent.com/trials/the-study-of-biodistribution-and-dosimetry-of-99mtc-glycopeptide-99mtc-gp-in-patients-with-breast-cancer-39327https://curecurrent.com/trials/extended-release-of-octreotide-lf-pb-for-the-treatment-of-lymphorrhea-39328https://curecurrent.com/trials/study-of-anastrozole-azd8931-in-postmenopausal-women-with-endocrine-therapy-naive-breast-cancer-39329https://curecurrent.com/trials/study-of-the-icg-distribution-in-breast-tumours-or-in-axillary-lymph-nodes-of-patients-after-neoadjuvant-therapy-39330https://curecurrent.com/trials/evaluation-of-cabazitaxel-in-patients-with-brain-metastasis-secondary-to-breast-cancer-and-nsclc-39331https://curecurrent.com/trials/evaluation-of-two-techniques-for-the-sln-detection-in-bc-patients-39332https://curecurrent.com/trials/stride-stimulating-immune-response-in-advanced-breast-cancer-39333https://curecurrent.com/trials/an-analysis-of-the-response-of-human-tumor-microvascular-endothelium-to-ionizing-radiation-39334https://curecurrent.com/trials/clinical-trial-effectiveness-and-efficiency-of-physical-exercise-in-cancer-patients-39335https://curecurrent.com/trials/omega-3-fatty-acid-on-joint-symptoms-inducted-by-aromatase-inhibitors-39336https://curecurrent.com/trials/nipple-aspiration-ductal-lavage-and-duct-endoscopy-in-screening-women-at-moderate-to-high-risk-of-developing-breast-canc-39337https://curecurrent.com/trials/domiciliary-physiotherapy-during-breast-cancer-radiation-39338https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-taxane-based-chemotherapy-as-first-line-treatment-in-patients-with-he-39339https://curecurrent.com/trials/weekly-and-every-3-week-administration-of-paclitaxel-liposome-injection-in-metastatic-breast-cancer-39340https://curecurrent.com/trials/non-invasive-detection-of-lung-and-breast-cancer-by-odor-signature-39341https://curecurrent.com/trials/lapatinib-combined-with-paclitaxel-for-patients-with-first-line-erbb2-amplified-metastatic-breast-cancer-39342https://curecurrent.com/trials/electrochemotherapy-for-chest-wall-recurrence-af-breast-cancer-present-challenges-and-future-prospects-39343https://curecurrent.com/trials/a-study-to-compare-etc-vs-ec-tx-and-ibandronate-vs-observation-in-patients-with-node-positive-primary-breast-cancer-gain-39344https://curecurrent.com/trials/study-in-elderly-patients-with-early-breast-cancer-ice-39345https://curecurrent.com/trials/comparing-anastrozole-placebo-to-the-combination-anastrozole-zd1839-in-postmenopausal-patients-with-estrogen-receptor-an-39346https://curecurrent.com/trials/spectroscopy-of-breast-tissue-39347https://curecurrent.com/trials/docetaxel-alone-or-in-combination-with-vaccine-to-treat-breast-cancer-39348https://curecurrent.com/trials/study-of-the-safety-and-leukostimulatory-activity-of-the-preparation-panagen-in-patients-with-breast-cancer-39349https://curecurrent.com/trials/a-phase-ii-study-of-e7389-in-patients-with-breast-cancer-previously-treated-with-anthracycline-taxane-and-capecitabine-39350https://curecurrent.com/trials/genetically-informed-therapies-for-patients-with-metastatic-cancer-39351https://curecurrent.com/trials/gemcitabine-as-a-single-agent-in-the-maintenance-chemotherapy-of-patients-with-metastatic-breast-cancer-39352https://curecurrent.com/trials/lapatinib-vinorelbine-in-erbb2-overexpressing-first-or-second-line-metastatic-breast-cancer-subjects-39353https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-chemotherapy-in-patients-with-primary-breast-cancer-39354https://curecurrent.com/trials/ambulatory-snp-under-local-anaesthesia-in-a-subgroup-of-breast-cancer-patients-trial-39355https://curecurrent.com/trials/study-of-gtx-024-on-muscle-wasting-cachexia-cancer-39356https://curecurrent.com/trials/exercise-intervention-study-for-early-stage-breast-cancer-patients-receiving-neoadjuvant-therapy-39357https://curecurrent.com/trials/study-assessing-safety-and-tolerability-of-azd8931-alone-or-in-combination-with-paclitaxel-in-japanese-patients-39358https://curecurrent.com/trials/biological-therapy-in-treating-patients-with-advanced-cancer-39359https://curecurrent.com/trials/tamoxifen-in-the-prevention-of-breast-cancer-in-hodgkin-s-disease-survivors-39360https://curecurrent.com/trials/comparison-of-mri-and-molecular-breast-imaging-in-breast-diagnostic-evaluation-39361https://curecurrent.com/trials/combination-of-weekly-paclitaxel-with-neratinib-and-trastuzumab-in-women-with-metastatic-her2-positive-breast-cancer-39362https://curecurrent.com/trials/diagnosis-and-management-of-myofascial-pain-syndrome-in-women-with-mastectomies-39363https://curecurrent.com/trials/simultaneous-study-of-gemcitabine-docetaxel-combination-adjuvant-treatment-as-well-as-extended-bisphosphonate-and-survei-39364https://curecurrent.com/trials/lapatinib-and-paclitaxel-in-treating-patients-with-advanced-solid-tumors-39365https://curecurrent.com/trials/effect-of-metformin-on-breast-cancer-metabolism-39366https://curecurrent.com/trials/lapatinib-in-treating-patients-with-advanced-or-metastatic-breast-cancer-that-overexpresses-her2-39367https://curecurrent.com/trials/an-open-label-randomized-phase-ii-study-of-the-efficacy-and-safety-of-indisulam-e7070-in-combination-with-capecitabine-39368https://curecurrent.com/trials/perioperative-administration-of-cox-2-inhibitors-and-beta-blockers-to-women-undergoing-breast-cancer-surgery-39369https://curecurrent.com/trials/marginprobe-a-device-for-intraoperative-assessment-of-margin-status-in-breast-conservation-surgery-39370https://curecurrent.com/trials/pilot-study-about-tamoxifen-therapy-for-breast-cancer-patients-39371https://curecurrent.com/trials/intensity-modulated-radiotherapy-imrt-vs-3d-conformal-accelerated-partial-breast-irradiation-apbi-for-early-stage-breast-39372https://curecurrent.com/trials/study-of-arimidex-and-radiotherapy-sequencing-39373https://curecurrent.com/trials/bay88-8223-alpharadin-breast-cancer-patients-with-bone-dominant-disease-39374https://curecurrent.com/trials/sentinel-node-biopsy-and-axillary-sampling-in-operable-breast-cancer-39375https://curecurrent.com/trials/liposomal-daunorubicin-in-treating-patients-with-metastatic-breast-cancer-39376https://curecurrent.com/trials/development-of-a-personalised-care-plan-designed-to-reduce-chronic-post-operative-pain-following-breast-surgery-39377https://curecurrent.com/trials/aromatase-inhibitors-in-premenopausal-breast-cancer-patients-with-chemotherapy-induced-ovarian-failure-39378https://curecurrent.com/trials/the-accuracy-of-sentinel-node-biopsy-of-breast-cancer-with-sonographic-abnormal-axillary-lymph-nodes-39379https://curecurrent.com/trials/a-study-of-rhumab-vegf-bevacizumab-in-combination-with-chemotherapy-in-patients-with-previously-treated-breast-cancer-39380https://curecurrent.com/trials/impact-of-adjuvant-treatment-with-aromatase-inhibitor-on-sleep-disturbances-in-postmenopausal-women-with-endocrine-respo-39381https://curecurrent.com/trials/a-study-of-ramucirumab-imc-1121b-in-participants-with-breast-cancer-39382https://curecurrent.com/trials/a-prevention-trial-in-subjects-at-high-risk-for-breast-cancer-39383https://curecurrent.com/trials/compression-bandaging-and-manual-lymph-drainage-in-women-with-lymphedema-39384https://curecurrent.com/trials/dose-escalating-study-for-amphinex-based-pci-of-bleomycin-39385https://curecurrent.com/trials/heated-chemotherapy-for-cancers-that-have-spread-to-the-chest-cavity-39386https://curecurrent.com/trials/paravertebral-block-an-adjunct-to-general-anaesthesia-for-breast-surgery-39387https://curecurrent.com/trials/the-prognostic-value-of-fdg-pet-ct-and-diffusion-weighed-imaging-on-breast-cancer-39388https://curecurrent.com/trials/breast-cancer-biomarker-sample-collection-for-the-dtectdx-assay-verification-39389https://curecurrent.com/trials/phase-ii-trial-of-bibw-2992-in-patients-with-her2-positive-metastatic-breast-cancer-after-failure-of-trastuzumab-therapy-39390https://curecurrent.com/trials/s0338-imatinib-mesylate-and-capecitabine-in-treating-women-with-progressive-stage-iv-breast-cancer-39391https://curecurrent.com/trials/reproducibility-of-18f-uptake-by-solid-tumors-using-pet-imaging-following-intravenous-administration-of-18f-injection-39392https://curecurrent.com/trials/contrast-the-role-of-avitene-and-ok-432-in-reducing-seroma-formation-after-axillary-lymphadenectomy-for-breast-cancer-39393https://curecurrent.com/trials/a-pilot-observational-study-to-assess-changes-in-biochemical-parameters-of-ovarian-reserve-with-chemotherapy-39394https://curecurrent.com/trials/outcomes-after-perforator-flap-reconstruction-for-breast-reconstruction-and-or-lymphedema-treatment-39395https://curecurrent.com/trials/adjuvant-toremifene-with-or-without-goserrelin-in-premenopausal-women-with-stage-i-iiia-hormonal-receptor-positive-breas-39396https://curecurrent.com/trials/genomic-proteomic-analysis-of-docetaxel-capecitabine-as-primary-chemo-for-stage-ii-iii-breast-cancer-39397https://curecurrent.com/trials/vaginal-testosterone-cream-vs-estring-for-vaginal-dryness-or-decreased-libido-in-early-stage-breast-cancer-patients-39398https://curecurrent.com/trials/trastuzumab-and-ixabepilone-in-treating-women-with-her2-positive-metastatic-breast-cancer-39399https://curecurrent.com/trials/vorinostat-and-trastuzumab-in-treating-patients-with-metastatic-or-locally-recurrent-breast-cancer-39400https://curecurrent.com/trials/dynamic-contrast-enhanced-mri-in-patients-with-advanced-breast-or-pancreatic-cancer-with-metastases-to-the-liver-or-lung-39401https://curecurrent.com/trials/level-of-physical-activities-in-patients-before-and-after-breast-cancer-treatment-39402https://curecurrent.com/trials/compound-herbal-formula-tpe-1-for-leukopenia-and-cancer-related-fatigue-in-breast-cancer-patients-with-radiotherapy-39403https://curecurrent.com/trials/sorafenib-and-anastrozole-in-treating-postmenopausal-women-with-metastatic-breast-cancer-39404https://curecurrent.com/trials/s9313b-study-of-tumor-tissue-samples-from-women-with-early-stage-breast-cancer-enrolled-on-clinical-trial-swog-9313-39405https://curecurrent.com/trials/brain-metastasis-in-breast-cancer-patients-39406https://curecurrent.com/trials/combination-chemotherapy-with-or-without-trastuzumab-in-treating-women-with-metastatic-breast-cancer-39407https://curecurrent.com/trials/radiation-therapy-plus-paclitaxel-in-treating-patients-with-stage-iib-or-stage-iii-breast-cancer-39408https://curecurrent.com/trials/clinical-trial-of-gemcitabine-and-oxaliplatin-in-recurrent-or-metastatic-breast-cancer-39409https://curecurrent.com/trials/lapatinib-in-combination-with-radiation-therapy-in-patients-with-brain-metastases-from-her2-positive-breast-cancer-39410https://curecurrent.com/trials/a-pilot-clinical-trial-to-evaluate-the-biological-activity-of-fulvestrant-in-breast-ductal-carcinoma-in-situ-dcis-39411https://curecurrent.com/trials/iron-supplement-in-the-prevention-of-anemia-in-female-breast-cancer-patients-39412https://curecurrent.com/trials/feasibility-study-of-metronomic-chemotherapy-for-locally-advanced-her2-positive-breast-cancer-traq-me-01-39413https://curecurrent.com/trials/trastuzumab-ixabepilone-and-carboplatin-in-treating-patients-with-her2-neu-positive-metastatic-breast-cancer-39414https://curecurrent.com/trials/feasibility-study-of-metronomic-chemotherapy-for-locally-advanced-her2-negative-breast-cancer-39415https://curecurrent.com/trials/national-screening-in-denmark-with-mr-versus-mammography-and-ultrasound-of-women-with-brca1-or-brca2-mutations-39416https://curecurrent.com/trials/the-role-of-diet-and-lifestyle-in-breast-cancer-survival-39417https://curecurrent.com/trials/effect-of-zoledronic-acid-as-anti-cancer-treatment-in-metastatic-breast-cancer-patients-39418https://curecurrent.com/trials/1st-or-2nd-line-mbc-metastatic-breast-cancer-with-previous-avastin-bevacizumab-therapy-39419https://curecurrent.com/trials/perioperative-inflammation-and-breast-cancer-outcome-39420https://curecurrent.com/trials/bevacizumab-and-combination-chemotherapy-in-patients-with-lymph-node-positive-breast-cancer-39421https://curecurrent.com/trials/sequential-administration-of-fe75c-and-docetaxel-versus-docetaxel-cyclophosphamide-in-her-2-negative-node-positive-breas-39422https://curecurrent.com/trials/the-use-of-laser-assisted-indocyanine-green-dye-angiography-to-predict-mastectomy-skin-flap-viability-39423https://curecurrent.com/trials/a-phase-ii-study-of-neoadjuvant-trastuzumab-docetaxel-npld-bevacizumab-in-her2-pos-early-breast-cancer-39424https://curecurrent.com/trials/anastrozole-and-zd1839-compared-with-fulvestrant-and-zd1839-in-postmenopausal-women-w-metastatic-breast-cancer-39425https://curecurrent.com/trials/study-of-motexafin-gadolinium-with-whole-brain-radiation-therapy-followed-by-stereotactic-radiosurgery-boost-in-the-trea-39426https://curecurrent.com/trials/a-phase-ii-multi-center-pilot-study-of-concurrent-temozolomide-and-whole-brain-irradiation-in-lung-cancer-and-breast-can-39427https://curecurrent.com/trials/the-role-of-myocardial-spect-in-evaluation-of-irradiation-induced-changes-39428https://curecurrent.com/trials/online-stress-management-and-coping-skills-training-for-women-with-breast-cancer-39429https://curecurrent.com/trials/randomized-trial-of-exemestane-versus-continued-tamoxifen-in-postmenopausal-women-with-early-breast-cancer-39430https://curecurrent.com/trials/sulindac-and-docetaxel-in-treating-women-with-metastatic-or-recurrent-breast-cancer-39431https://curecurrent.com/trials/evaluation-of-beauty-care-before-chemotherapy-in-women-with-breast-cancer-39432https://curecurrent.com/trials/the-effect-of-melatonin-on-depression-anxiety-cognitive-function-and-sleep-disturbances-in-breast-cancer-patients-39433https://curecurrent.com/trials/hypertension-in-breast-cancer-patients-receiving-bevacizumab-39434https://curecurrent.com/trials/efficacy-and-tolerability-of-toremifene-or-tamoxifen-therapy-in-premenopausal-estrogen-and-progesterone-receptor-positiv-39435https://curecurrent.com/trials/mri-evaluation-of-the-breast-areolar-margin-and-paryenchyma-39436https://curecurrent.com/trials/vegf-trap-in-treating-patients-with-metastatic-breast-cancer-39437https://curecurrent.com/trials/hatha-yoga-in-improving-physical-activity-inflammation-fatigue-and-distress-in-breast-cancer-survivors-39438https://curecurrent.com/trials/prevention-of-graft-versus-host-disease-in-patients-undergoing-bone-marrow-transplantation-39439https://curecurrent.com/trials/cardiotoxicity-in-metastatic-her-2-positive-patients-treated-with-trastuzumab-pertuzumab-and-taxanes-39440https://curecurrent.com/trials/effect-of-aromatase-inhibitors-on-breast-magnetic-resonance-imaging-mri-39441https://curecurrent.com/trials/rapid-medical-donation-programme-for-breast-cancer-39442https://curecurrent.com/trials/saracatinib-in-treating-patients-with-metastatic-or-locally-advanced-breast-cancer-that-cannot-be-removed-by-surgery-39443https://curecurrent.com/trials/regional-anesthesia-versus-general-anesthesia-on-circulating-tumor-cells-ctc-39444https://curecurrent.com/trials/rpfna-assessment-of-exercise-effect-in-breast-cancer-39445https://curecurrent.com/trials/usefulness-of-myocardial-deformation-imaging-for-trastuzumab-induced-cardiotoxicity-39446https://curecurrent.com/trials/impact-of-cancer-on-memory-functioning-understanding-disorders-using-approaches-in-neuropsychology-and-neuroimaging-39447https://curecurrent.com/trials/efficacy-of-a-web-based-tailored-self-management-program-39448https://curecurrent.com/trials/single-dosing-of-zoledronic-acid-in-cancer-therapy-induced-bone-loss-ctibl-39449https://curecurrent.com/trials/psychosocial-adjustment-of-patients-and-their-partners-following-breast-cancer-diagnosis-39450https://curecurrent.com/trials/a-phase-ii-study-comparing-pegylated-rhg-csf-hhpg-19k-and-rhg-csf-in-breast-cancer-patients-receiving-chemotherapy-39451https://curecurrent.com/trials/pharmacokinetic-study-of-tesmilifene-ymb1002-plus-epirubicin-and-cyclophosphamide-in-metastatic-breast-cancer-39452https://curecurrent.com/trials/a-study-of-docetaxel-monotherapy-or-doxil-and-docetaxel-in-patients-with-advanced-breast-cancer-39453https://curecurrent.com/trials/aromatase-cyp19-polymorphism-between-ai-responsive-and-ai-resistant-breast-cancer-in-korea-39454https://curecurrent.com/trials/guilford-genomic-medicine-initiative-ggmi-39455https://curecurrent.com/trials/18f-fdg-pet-metabolic-phenotype-in-evaluating-therapeutic-response-for-breast-cancer-patients-with-bone-metastases-39456https://curecurrent.com/trials/neoadjuvant-trial-of-capecitabine-for-axillary-lymph-node-positive-operable-breast-cancer-39457https://curecurrent.com/trials/phase-ii-study-of-carboplatin-and-bevacizumab-avastin-for-er-neg-pr-neg-and-her2-neu-neg-metastatic-breast-cancer-39458https://curecurrent.com/trials/low-fat-versus-protein-sparing-diet-for-weight-loss-impact-on-biomarkers-associated-with-breast-cancer-risk-39459https://curecurrent.com/trials/a-study-to-assess-the-potential-effects-of-a-single-dose-administration-of-trabectedin-on-the-qt-intervals-of-the-electr-39460https://curecurrent.com/trials/the-effects-of-pre-operative-physical-therapy-education-39461https://curecurrent.com/trials/lifestyle-exercise-and-nutrition-study-1-39462https://curecurrent.com/trials/high-intensity-focused-ultrasound-hifu-to-treat-breast-fibroadenoma-39463https://curecurrent.com/trials/decision-support-for-women-with-breast-cancer-39464https://curecurrent.com/trials/rad001-plus-carboplatin-in-breast-cancer-patients-39465https://curecurrent.com/trials/phase-i-ii-study-of-mk-0752-followed-by-docetaxel-in-advanced-or-metastatic-breast-cancer-39466https://curecurrent.com/trials/phase-ii-study-of-intra-operative-electron-irradiation-and-external-beam-irradiation-after-lumpectomy-in-patients-with-t-39467https://curecurrent.com/trials/effect-of-a-low-glycemic-index-diet-on-breast-density-39468https://curecurrent.com/trials/breast-cancer-during-pregnancy-39469https://curecurrent.com/trials/veliparib-oxaliplatin-and-capecitabine-in-treating-patients-with-advanced-solid-tumors-39470https://curecurrent.com/trials/pharmacodynamic-study-of-bkm120-in-breast-cancer-39471https://curecurrent.com/trials/a-prospective-cohort-study-to-evaluate-the-oncotype-dx-test-in-early-stage-breast-cancer-39472https://curecurrent.com/trials/detection-of-aggressive-breast-tumors-using-tc-99m-nc100692-39473https://curecurrent.com/trials/toremifene-with-or-without-atamestane-in-treating-postmenopausal-women-with-metastatic-breast-cancer-39474https://curecurrent.com/trials/tumour-necrosis-factor-release-in-locally-advanced-breast-cancer-patients-receiving-neoadjuvant-docetaxel-39475https://curecurrent.com/trials/study-of-aeroform-tissue-expander-for-breast-reconstruction-39476https://curecurrent.com/trials/a-study-to-evaluate-avastin-in-patients-treated-in-a-previous-genentech-sponsored-cancer-study-39477https://curecurrent.com/trials/ultrasound-vs-predetermined-distance-techniques-for-paravertebral-nerve-block-in-patients-having-breast-surgery-39478https://curecurrent.com/trials/zoledronic-acid-letrozole-adjuvant-synergy-trial-zfast-cancer-treatment-related-bone-loss-in-postmenopausal-women-with-e-39479https://curecurrent.com/trials/assessment-of-the-efficacy-of-the-neoadjuvant-combination-chemotherapy-targeted-therapy-in-breast-cancer-39480https://curecurrent.com/trials/informed-decision-users-of-the-health-system-and-participation-in-organized-screening-for-breast-cancer-39481https://curecurrent.com/trials/assessment-of-the-efficacy-of-a-neoadjuvant-combination-chemotherapy-targeted-therapy-in-breast-cancer-39482https://curecurrent.com/trials/dual-blockage-with-afatinib-and-trastuzumab-as-neoadjuvant-treatment-for-patients-with-locally-advanced-or-operable-brea-39483https://curecurrent.com/trials/weekly-gemcitabine-and-trastuzumab-in-the-treatment-of-patients-with-human-epidermal-growth-factor-receptor-2-her2-posit-39484https://curecurrent.com/trials/lapatinib-vinorelbine-vs-vinorelbine-her2-positive-metastatic-breast-cancer-progressed-after-lapatinib-trastuzumab-39485https://curecurrent.com/trials/early-detection-of-graft-versus-host-disease-in-patients-undergoing-a-donor-bone-marrow-transplant-39486https://curecurrent.com/trials/characterization-of-brain-metastases-39487https://curecurrent.com/trials/concomitant-chemoradiotherapy-with-weekly-paclitaxel-and-vinorelbine-and-granulocyte-colony-stimulating-factor-gcsf-supp-39488https://curecurrent.com/trials/the-effects-of-peri-operative-pregabalin-on-post-operative-pain-following-breast-cancer-surgery-with-axillary-node-disse-39489https://curecurrent.com/trials/identification-of-sentinel-node-s-in-breast-cancer-39490https://curecurrent.com/trials/correlation-between-genetic-variants-and-long-term-cardiac-effects-induced-by-doxorubicin-in-breast-cancer-patients-39491https://curecurrent.com/trials/fentanyl-sublingual-spray-in-treating-patients-with-breakthrough-cancer-pain-39492https://curecurrent.com/trials/docetaxel-doxorubicin-and-cyclophosphamide-in-treating-women-with-advanced-breast-cancer-39493https://curecurrent.com/trials/partial-breast-irradiation-in-a-low-risk-population-screened-with-mri-39494https://curecurrent.com/trials/treatment-with-pazopanib-for-neoadjuvant-breast-cancer-39495https://curecurrent.com/trials/moderating-the-negative-impact-of-abnormal-screening-mammograms-39496https://curecurrent.com/trials/imaging-of-prostate-and-breast-cancer-bone-metastases-using-magnetic-resonance-imaging-and-nuclear-medicine-techniques-39497https://curecurrent.com/trials/epothilone-b-in-treating-patients-with-cns-metastases-from-breast-cancer-39498https://curecurrent.com/trials/combination-of-oral-wx-671-plus-capecitabine-vs-capecitabine-monotherapy-in-first-line-her2-negative-metastatic-breast-c-39499https://curecurrent.com/trials/a-treatment-with-fulvestrant-and-exemestane-in-postmenopausal-patients-with-advanced-hormone-receptor-positive-hr-breast-39500https://curecurrent.com/trials/biomarkers-in-blood-samples-from-older-breast-cancer-survivors-39501https://curecurrent.com/trials/mindfulness-based-stress-reduction-mbsr-symptom-cluster-trial-for-breast-cancer-survivors-39502https://curecurrent.com/trials/the-study-of-goserelin-plus-fulvestrant-comparing-with-goserelin-plus-anastrozole-for-advanced-breast-cancer-39503https://curecurrent.com/trials/an-efficacy-study-of-trabectedin-in-the-treatment-of-participants-with-specific-subtypes-of-metastatic-breast-cancer-39504https://curecurrent.com/trials/a-dose-finding-and-efficacy-study-of-the-tumour-targeting-human-131i-f16sip-monoclonal-antibody-in-patients-with-cancer-39505https://curecurrent.com/trials/combination-therapy-of-f16il2-and-doxorubicin-in-solid-tumour-patients-39506https://curecurrent.com/trials/afp464-in-treating-patients-with-metastatic-or-refractory-solid-tumors-that-cannot-be-removed-by-surgery-39507https://curecurrent.com/trials/modulation-of-response-to-hormonal-therapy-with-lapatinib-and-or-metformin-in-patients-with-metastatic-breast-cancer-39508https://curecurrent.com/trials/effect-of-a-diet-and-physical-activity-intervention-in-breast-cancer-survivors-39509https://curecurrent.com/trials/phase-ii-study-of-neoadjuvant-chemotherapy-regimen-choice-in-breast-cancer-39510https://curecurrent.com/trials/blood-test-for-breast-cancer-associated-auto-antibodies-improvement-of-octava-blood-test-39511https://curecurrent.com/trials/applicability-of-video-games-and-vibrational-therapy-in-reducing-pain-secondary-to-breast-cancer-39512https://curecurrent.com/trials/does-scar-massage-improve-postoperative-pain-and-function-in-women-with-breast-cancer-39513https://curecurrent.com/trials/quality-of-life-in-chinese-postmenopausal-hr-early-breast-cancer-ebc-patients-during-adjuvant-aromatase-inhibitors-ais-t-39514https://curecurrent.com/trials/cetuximab-and-cisplatin-in-the-treatment-of-triple-negative-estrogen-receptor-er-negative-progesterone-receptor-pgr-nega-39515https://curecurrent.com/trials/oral-microencapsulated-diindolylmethane-in-treating-patients-with-stage-ii-iii-triple-negative-androgen-receptor-positiv-39516https://curecurrent.com/trials/dose-dense-biweekly-carboplatin-plus-paclitaxel-with-or-without-trastuzumab-as-neoadjuvant-treatment-for-breast-cancer-39517https://curecurrent.com/trials/open-label-extension-to-sre-studies-in-united-kingdom-and-czech-republic-only-39518https://curecurrent.com/trials/outcomes-of-triaged-family-care-in-advanced-cancer-39519https://curecurrent.com/trials/endoscopic-breast-surgery-in-treating-patients-with-breast-cancer-39520https://curecurrent.com/trials/azacitidine-in-treating-patients-with-triple-negative-stage-i-iv-invasive-breast-cancer-that-can-be-removed-by-surgery-39521https://curecurrent.com/trials/developing-culturally-tailored-information-based-support-groups-for-chinese-immigrants-with-breast-cancer-39522https://curecurrent.com/trials/her-2-protein-vaccine-in-treating-women-with-breast-cancer-39523https://curecurrent.com/trials/the-biology-of-claudin-3-in-primary-human-mammary-epithelial-cell-culture-39524https://curecurrent.com/trials/systemic-therapy-with-or-without-upfront-surgery-in-metastatic-breast-cancer-39525https://curecurrent.com/trials/detection-and-or-evaluation-of-dense-breast-abnormalities-using-tomosynthesis-and-digital-mammography-39526https://curecurrent.com/trials/pneumatic-compression-treatment-for-upper-extremity-acquired-lymphedema-39527https://curecurrent.com/trials/epidemiology-and-management-of-metastatic-breast-cancer-39528https://curecurrent.com/trials/vorinostat-before-surgery-in-treating-patients-with-triple-negative-breast-cancer-39529https://curecurrent.com/trials/denosumab-amg-162-in-bisphosphonate-naive-metastatic-breast-cancer-39530https://curecurrent.com/trials/a-trial-of-tivozanib-av-951-in-combination-with-capecitabine-xeloda-in-subjects-with-advanced-solid-tumors-39531https://curecurrent.com/trials/fear-of-recurrence-pilot-intervention-for-women-with-breast-cancer-39532https://curecurrent.com/trials/dose-escalation-study-of-arq-197-in-combination-with-sorafenib-in-adult-patients-with-advanced-solid-tumors-39533https://curecurrent.com/trials/breast-cancer-aromatase-inhibitor-therapy-and-sexual-functioning-the-effects-of-vaginal-testosterone-therapy-39534https://curecurrent.com/trials/phase-ii-study-of-simvastatin-in-primary-breast-cancer-test-of-its-potential-selectivity-on-basal-subtype-breast-cancer-39535https://curecurrent.com/trials/analysis-of-prognostic-and-predictive-genomic-signatures-using-archival-paraffin-embedded-tumor-specimens-in-breast-canc-39536https://curecurrent.com/trials/comparative-genomic-and-genetic-analysis-of-paired-primary-breast-metastatic-tumor-specimens-using-high-throughput-platf-39537https://curecurrent.com/trials/biomarkers-of-fatigue-related-to-adjuvant-chemotherapy-for-breast-cancer-39538https://curecurrent.com/trials/a-non-interventional-study-with-aromasin-as-adjuvant-treatment-of-invasive-early-breast-cancer-39539https://curecurrent.com/trials/analysis-of-prognostic-and-predictive-genomic-signatures-using-archival-paraffin-embedded-breast-tumor-a-pilot-study-39540https://curecurrent.com/trials/a-study-of-loading-doses-of-intravenous-bondronat-ibandronate-in-patients-with-breast-cancer-and-malignant-bone-disease-39541https://curecurrent.com/trials/rapamycin-with-grapefruit-juice-for-advanced-malignancies-39542https://curecurrent.com/trials/quality-study-of-anesthetic-technique-on-breast-cancer-surgery-39543https://curecurrent.com/trials/ultrasound-targeting-for-the-lumpectomy-cavity-39544https://curecurrent.com/trials/sensory-morbidity-following-breast-surgery-39545https://curecurrent.com/trials/study-of-sar240550-bsi-201-in-combination-with-gemcitabine-carboplatin-in-patients-with-metastatic-triple-negative-breas-39546https://curecurrent.com/trials/behavioural-changes-in-breast-cancer-patients-39547https://curecurrent.com/trials/biomarker-study-of-breast-tumors-39548https://curecurrent.com/trials/development-of-predictive-biomarkers-and-novel-approached-to-therapy-in-breast-cancer-39549https://curecurrent.com/trials/prevention-of-breast-cancer-recurrence-through-weight-control-diet-and-physical-activity-intervention-39550https://curecurrent.com/trials/lapatinib-and-vinorelbine-in-treating-women-with-her2-overexpressing-locally-advanced-or-metastatic-breast-cancer-39551https://curecurrent.com/trials/breast-cancer-registry-national-university-health-system-singapore-39552https://curecurrent.com/trials/cyclophosphamide-radiation-therapy-and-poly-iclc-in-treating-patients-with-unresectable-recurrent-primary-or-metastatic-39553https://curecurrent.com/trials/trial-of-rad001-in-triple-negative-metastatic-breast-cancer-39554https://curecurrent.com/trials/addition-of-paclitaxel-to-high-dose-combination-chemotherapy-in-treating-women-with-metastatic-breast-cancer-39555https://curecurrent.com/trials/doxorubicin-hydrochloride-liposome-in-treating-women-with-ductal-carcinoma-in-situ-undergoing-surgery-39556https://curecurrent.com/trials/addition-of-paclitaxel-to-high-dose-combination-chemotherapy-in-treating-patients-with-high-risk-breast-cancer-39557https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-trastuzumab-emtansine-trastuzumab-mcc-dm1-vs-trastuzumab-herceptin-and-docetaxel-t-39558https://curecurrent.com/trials/multicenter-descriptive-study-of-the-patient-clinical-profile-that-begins-with-disseminated-her-2-breast-cancer-or-devel-39559https://curecurrent.com/trials/zoledronate-in-preventing-bone-loss-in-premenopausal-women-receiving-chemotherapy-after-surgery-for-early-stage-breast-c-39560https://curecurrent.com/trials/bevacizumab-doxorubicin-and-cyclophosphamide-followed-by-paclitaxel-albumin-stabilized-nanoparticle-formulation-and-beva-39561https://curecurrent.com/trials/chemotherapy-plus-peripheral-stem-cell-transplantation-compared-with-chemotherapy-alone-in-treating-women-with-stage-iv-39562https://curecurrent.com/trials/docetaxel-combined-with-estramustine-in-treating-women-with-metastatic-breast-cancer-39563https://curecurrent.com/trials/exemestane-plus-everolimus-for-hormone-receptor-positive-metastatic-breast-cancer-39564https://curecurrent.com/trials/an-open-label-phase-ii-trial-of-bibw-2992-in-patients-with-her2-negative-metastatic-breast-cancer-39565https://curecurrent.com/trials/exploratory-study-on-the-use-of-pregabalin-for-the-treatment-of-taxol-related-arthralgia-myalgia-39566https://curecurrent.com/trials/6-weeks-treatment-of-locally-advanced-breast-cancer-with-bibw-2992-afatinib-or-lapatinib-or-trastuzumab-39567https://curecurrent.com/trials/letrozole-and-cdk-4-6-inhibitor-for-er-positive-her2-negative-breast-cancer-in-postmenopausal-women-39568https://curecurrent.com/trials/bibw-2992-and-letrozole-in-hormonoresistant-metastatic-breast-cancer-39569https://curecurrent.com/trials/docetaxel-in-breast-cancer-39570https://curecurrent.com/trials/prognostic-value-of-stem-cell-related-markers-39571https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-trastuzumab-mcc-dm1-t-dm1-in-combination-with-pertuzumab-administered-to-patients-with-39572https://curecurrent.com/trials/bevacizumab-with-or-without-cyclophosphamide-and-methotrexate-a-pilot-study-in-women-with-operable-breast-cancer-39573https://curecurrent.com/trials/lapatinib-plus-caelyx-in-patients-with-advanced-metastatic-breast-cancer-following-failure-of-trastuzumab-therapy-39574https://curecurrent.com/trials/anti-proliferative-effects-and-genomic-alterations-of-abiraterone-acetate-compared-to-an-aromatase-inhibitor-in-post-men-39575https://curecurrent.com/trials/exemestane-compared-with-tamoxifen-in-treating-postmenopausal-women-with-primary-breast-cancer-39576https://curecurrent.com/trials/peptide-profiles-of-women-undergoing-breast-biopsy-39577https://curecurrent.com/trials/radiation-therapy-after-surgery-in-treating-women-with-early-stage-breast-cancer-39578https://curecurrent.com/trials/adjuvant-chemotherapy-plus-radiation-therapy-in-treating-women-with-early-stage-breast-cancer-39579https://curecurrent.com/trials/combination-chemotherapy-with-or-without-microwave-thermotherapy-before-surgery-in-treating-women-with-locally-advanced-39580https://curecurrent.com/trials/biological-therapy-in-treating-women-with-metastatic-breast-cancer-39581https://curecurrent.com/trials/tamoxifen-in-treating-women-with-breast-cancer-39582https://curecurrent.com/trials/evaluation-of-drug-resistance-in-patients-with-metastatic-breast-cancer-39583https://curecurrent.com/trials/edotecarin-in-treating-women-with-locally-advanced-or-metastatic-breast-cancer-that-has-not-responded-to-chemotherapy-39584https://curecurrent.com/trials/su006668-in-treating-patients-with-advanced-solid-tumors-39585https://curecurrent.com/trials/doxorubicin-in-treating-women-with-advanced-breast-cancer-39586https://curecurrent.com/trials/combination-chemotherapy-with-or-without-epirubicin-in-treating-women-with-stage-i-or-stage-ii-breast-cancer-39587https://curecurrent.com/trials/radiation-therapy-after-surgery-in-treating-women-with-early-stage-breast-cancer-39588https://curecurrent.com/trials/effect-of-dietary-soy-on-estrogens-in-breast-fluid-blood-and-urine-samples-from-healthy-women-39589https://curecurrent.com/trials/celecoxib-and-trastuzumab-in-treating-women-with-metastatic-breast-cancer-39590https://curecurrent.com/trials/emergency-use-of-donor-lymphocytes-in-treating-patients-who-have-undergone-donor-stem-cell-transplant-and-have-cytomegal-39591https://curecurrent.com/trials/perillyl-alcohol-in-preventing-recurrent-breast-cancer-in-women-who-have-been-treated-with-surgery-with-or-without-adjuv-39592https://curecurrent.com/trials/epirubicin-and-tamoxifen-with-or-without-docetaxel-in-treating-postmenopausal-women-with-breast-cancer-39593https://curecurrent.com/trials/liposomal-doxorubicin-and-gemcitabine-in-treating-women-with-metastatic-breast-cancer-39594https://curecurrent.com/trials/genes-that-affect-disease-progression-in-women-with-newly-diagnosed-or-metastatic-breast-cancer-39595https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-stage-ii-or-stage-iii-breast-cancer-39596https://curecurrent.com/trials/hyperbaric-oxygen-therapy-compared-with-standard-therapy-in-treating-chronic-arm-lymphedema-in-patients-who-have-undergo-39597https://curecurrent.com/trials/combination-chemotherapy-compared-with-mitoxantrone-in-treating-older-patients-with-advanced-breast-cancer-39598https://curecurrent.com/trials/a-weight-loss-program-in-helping-obese-black-women-lose-weight-39599https://curecurrent.com/trials/abi-007-and-bevacizumab-in-treating-women-with-recurrent-or-metastatic-breast-cancer-39600https://curecurrent.com/trials/capecitabine-in-treating-women-with-advanced-or-metastatic-breast-cancer-39601https://curecurrent.com/trials/gene-expression-in-predicting-response-to-paclitaxel-in-patients-with-breast-cancer-39602https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-bevacizumab-in-combination-with-chemotherapy-in-untreated-metastatic-breas-39603https://curecurrent.com/trials/bay43-9006-phase-ii-in-advanced-breast-cancer-39604https://curecurrent.com/trials/figitumumab-combined-with-pegvisomant-for-advanced-solid-tumors-39605https://curecurrent.com/trials/standardization-research-of-tcm-syndrome-differentiation-and-treatment-on-advanced-breast-cancer-39606https://curecurrent.com/trials/a-phase-ii-trial-of-gemcitabine-and-oxaliplatin-for-triple-negative-metastatic-breast-cancer-39607https://curecurrent.com/trials/serum-proteomics-to-predict-gemcitabine-sensitivity-in-breast-cancer-39608https://curecurrent.com/trials/uncovering-potential-breast-cancer-biomarkers-amp-possible-drug-targets-using-advanced-quantitative-mass-spectrometry-39609https://curecurrent.com/trials/knowledge-and-attitudes-of-patients-and-healthcare-professionals-on-a-spectrum-of-genetic-tests-relevant-to-breast-cance-39610https://curecurrent.com/trials/a-prospective-study-to-evaluate-the-effect-of-systemic-adjuvant-therapy-on-the-cognitive-function-of-breast-cancer-patie-39611https://curecurrent.com/trials/study-of-circulating-and-tumor-biomarkers-in-breast-cancer-patients-39612https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-metastatic-breast-cancer-39613https://curecurrent.com/trials/validate-gene-expression-and-proteomic-signatures-predictive-of-treatment-for-response-for-breast-cancer-patient-39614https://curecurrent.com/trials/clinical-trial-of-saha-in-patients-with-breast-cancer-39615https://curecurrent.com/trials/using-national-university-cancer-institute-of-singapore-ncis-registry-to-measure-time-trends-in-quality-of-care-for-brea-39616https://curecurrent.com/trials/deep-sequencing-of-the-breast-cancer-transcriptome-39617https://curecurrent.com/trials/nitrocamptothecin-in-treating-patients-with-locally-recurrent-or-metastatic-breast-cancer-39618https://curecurrent.com/trials/monoclonal-antibody-therapy-in-treating-women-with-locally-advanced-or-metastatic-breast-cancer-previously-treated-with-39619https://curecurrent.com/trials/psychosocial-treatment-for-improving-chances-of-survival-in-women-with-breast-cancer-39620https://curecurrent.com/trials/epirubicin-and-cyclophosphamide-compared-with-epirubicin-and-paclitaxel-in-treating-women-with-metastatic-breast-cancer-39621https://curecurrent.com/trials/a-study-of-famitinib-malate-in-her2-negative-metastatic-breast-cancer-39622https://curecurrent.com/trials/a-study-of-apatinib-in-non-triple-negative-metastatic-breast-cancer-39623https://curecurrent.com/trials/reducing-underuse-of-early-stage-breast-cancer-treatment-in-minority-communities-39624https://curecurrent.com/trials/patient-centered-randomized-controlled-trial-39625https://curecurrent.com/trials/exercise-controls-tumor-cell-growth-through-ampk-activation-39626https://curecurrent.com/trials/d-cycloserine-in-the-management-of-chemotherapy-induced-peripheral-neuropathic-pain-39627https://curecurrent.com/trials/prediction-of-pain-after-breast-cancer-surgery-with-eeg-39628https://curecurrent.com/trials/h-e-r-o-s-study-an-observational-study-of-the-cardiac-safety-of-herceptin-trastuzumab-in-patients-with-her2-positive-bre-39629https://curecurrent.com/trials/trial-of-inquiry-based-stress-reduction-ibsr-program-for-brca1-2-mutation-carriers-39630https://curecurrent.com/trials/effect-of-combined-exercise-post-treatment-intervention-in-lean-mass-recovery-in-breast-cancer-survival-39631https://curecurrent.com/trials/prolactin-receptor-and-breast-diseases-39632https://curecurrent.com/trials/etude-tomos-apport-de-la-tomosynth-se-dans-le-bilan-d-extension-locor-gional-pr-th-rapeutique-d-une-tumeur-du-sein-reche-39633https://curecurrent.com/trials/comparison-study-of-breast-tomosynthesis-slice-thicknesses-39634https://curecurrent.com/trials/an-evaluation-of-stereoscopic-digital-mammography-for-earlier-detection-of-breast-cancer-and-reduced-rate-of-recall-39635https://curecurrent.com/trials/trastuzumab-docetaxel-and-carboplatin-in-treating-women-with-stage-ii-stage-iii-or-inflammatory-breast-cancer-39636https://curecurrent.com/trials/a-pilot-study-of-cyberknife-radiosurgery-delivered-to-the-partial-breast-39637https://curecurrent.com/trials/testing-spectrosense-eva-system-for-detection-of-breast-cancer-by-analyzing-volatile-organic-compounds-vocs-in-exhaled-a-39638https://curecurrent.com/trials/an-observational-study-of-indian-breast-cancer-patients-receiving-adjuvant-therapy-with-aromasin-39639https://curecurrent.com/trials/a-randomized-controlled-comparative-study-of-ultrasound-guided-paravertebral-blocks-as-part-of-a-multimodal-regimen-for-39640https://curecurrent.com/trials/zd6474-zactima-and-metronomic-chemotherapy-in-advanced-breast-cancer-39641https://curecurrent.com/trials/trial-to-evaluate-the-therapeutic-benefit-of-fulvestrant-in-combination-with-zactima-in-postmenopausal-women-with-bone-p-39642https://curecurrent.com/trials/measuring-patient-satisfaction-and-quality-of-life-following-body-image-altering-surgery-39643https://curecurrent.com/trials/s0308-zoledronate-or-ibandronate-in-preventing-bone-problems-in-women-with-stage-iv-breast-cancer-that-has-spread-to-the-39644https://curecurrent.com/trials/lapatinib-and-doxorubicin-hydrochloride-liposome-in-treating-patients-with-metastatic-breast-cancer-39645https://curecurrent.com/trials/fulvestrant-or-tamoxifen-in-treating-postmenopausal-women-who-are-undergoing-surgery-for-ductal-carcinoma-in-situ-of-the-39646https://curecurrent.com/trials/standard-chemotherapy-compared-with-high-dose-combination-chemotherapy-and-peripheral-stem-cell-transplantation-in-treat-39647https://curecurrent.com/trials/vitamin-e-and-pentoxifylline-in-treating-women-with-lymphedema-after-radiation-therapy-for-breast-cancer-39648https://curecurrent.com/trials/high-dose-megestrol-in-treating-patients-with-metastatic-breast-cancer-endometrial-cancer-or-mesothelioma-39649https://curecurrent.com/trials/sentinel-lymph-node-biopsy-to-assess-axillary-lymph-nodes-in-women-with-stage-i-or-stage-ii-breast-cancer-39650https://curecurrent.com/trials/tamoxifen-following-combination-chemotherapy-in-treating-women-with-operable-invasive-breast-cancer-39651https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-breast-cancer-39652https://curecurrent.com/trials/comparison-of-three-combination-chemotherapy-regimens-in-treating-women-with-stage-i-or-stage-ii-breast-cancer-39653https://curecurrent.com/trials/immunotherapy-in-treating-patients-with-metastatic-breast-cancer-39654https://curecurrent.com/trials/axillary-drainage-following-lymph-node-dissection-in-women-with-stage-i-or-stage-ii-breast-cancer-39655https://curecurrent.com/trials/tamoxifen-ovarian-ablation-and-or-combination-chemotherapy-in-treating-premenopausal-women-with-stage-i-stage-ii-or-stag-39656https://curecurrent.com/trials/enhanced-ultrasound-in-determining-extent-of-disease-in-women-with-primary-breast-cancer-39657https://curecurrent.com/trials/microwave-thermotherapy-in-treating-women-with-stage-i-or-stage-ii-breast-cancer-39658https://curecurrent.com/trials/ih636-grape-seed-extract-in-treating-hardening-of-breast-tissue-in-women-who-have-undergone-radiation-therapy-for-early-39659https://curecurrent.com/trials/era-923-in-treating-postmenopausal-women-with-metastatic-breast-cancer-39660https://curecurrent.com/trials/standard-chemotherapy-compared-with-high-dose-chemotherapy-plus-peripheral-stem-cell-transplant-in-treating-women-with-a-39661https://curecurrent.com/trials/tamoxifen-with-or-without-combination-chemotherapy-in-treating-postmenopausal-women-with-operable-invasive-breast-cancer-39662https://curecurrent.com/trials/combination-chemotherapy-following-surgery-in-treating-women-with-early-stage-breast-cancer-39663https://curecurrent.com/trials/irs-proteins-and-trastuzumab-resistance-39664https://curecurrent.com/trials/safety-study-of-calaa-01-to-treat-solid-tumor-cancers-39665https://curecurrent.com/trials/hypodontia-and-ovarian-cancer-39666https://curecurrent.com/trials/liposomal-doxorubicin-before-mastectomy-in-treating-women-with-invasive-breast-cancer-39667https://curecurrent.com/trials/study-to-assess-efficacy-of-risedronate-in-preventing-bone-loss-in-postmenopausal-women-treated-for-breast-cancer-39668https://curecurrent.com/trials/choline-quantification-in-breast-cancer-by-mrs-39669https://curecurrent.com/trials/effect-of-diet-and-exercise-in-breast-cancer-survivors-39670https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-breast-cancer-39671https://curecurrent.com/trials/pazopanib-vinorelbine-in-non-small-cell-lung-cancer-nsclc-and-breast-cancer-39672https://curecurrent.com/trials/clinical-and-pharmacological-study-with-2b3-101-in-patients-with-breast-cancer-and-leptomeningeal-metastases-39673https://curecurrent.com/trials/comparison-of-complete-axillary-lymph-node-dissection-with-axillary-radiation-therapy-in-treating-women-with-invasive-br-39674https://curecurrent.com/trials/art-therapy-intervention-for-breast-cancer-patients-39675https://curecurrent.com/trials/the-physical-and-psychological-benefits-of-yoga-and-breast-cancer-39676https://curecurrent.com/trials/collection-of-fujifilm-s-3dimensional-mammograms-39677https://curecurrent.com/trials/anastrozole-with-or-without-gefitinib-in-treating-postmenopausal-women-with-metastatic-or-locally-recurrent-breast-cance-39678https://curecurrent.com/trials/biomarker-p53-gene-analysis-and-combination-chemotherapy-followed-by-radiation-therapy-and-surgery-in-treating-women-wit-39679https://curecurrent.com/trials/faith-moves-mountains-a-community-based-participatory-research-cbpr-appalachian-wellness-cancer-prevention-program-39680https://curecurrent.com/trials/a-randomized-open-label-phase-iii-trial-of-mapisal-versus-an-urea-hand-foot-cream-as-prophylaxis-for-capecitabine-induce-39681https://curecurrent.com/trials/computer-based-comprehensive-geriatric-assessment-in-oncology-for-individuals-70-or-older-with-gastrointestinal-malignan-39682https://curecurrent.com/trials/bibw-2992-afatinib-and-vinorelbine-39683https://curecurrent.com/trials/bevacizumab-with-etoposide-and-cisplatin-in-breast-cancer-patients-with-brain-and-or-leptomeningeal-metastasis-39684https://curecurrent.com/trials/mcghan-medical-silicone-filled-breast-implant-adjunct-study-39685https://curecurrent.com/trials/a-continuing-cancer-service-model-emphasizing-on-functional-restoration-model-for-breast-cancer-39686https://curecurrent.com/trials/18f-flt-positron-emission-tomography-and-magnetic-resonance-imaging-of-the-breast-39687https://curecurrent.com/trials/stereotactic-directional-vacuum-assisted-breast-biopsy-39688https://curecurrent.com/trials/use-of-trastuzumab-to-induce-increased-er-expression-in-er-negative-low-her-2-neu-positive-breast-cancer-39689https://curecurrent.com/trials/pain-management-following-tram-flap-for-breast-reconstruction-39690https://curecurrent.com/trials/phase-ii-trial-of-oxaliplatin-in-combination-with-s-1-sox-in-patients-with-recurrent-or-metastatic-breast-cancer-39691https://curecurrent.com/trials/magnetic-resonance-imaging-in-women-receiving-chemotherapy-for-stage-iii-breast-cancer-39692https://curecurrent.com/trials/trastuzumab-and-interleukin-2-in-treating-patients-with-metastatic-breast-cancer-39693https://curecurrent.com/trials/effectiveness-of-accelerated-intervention-with-compression-sleeve-in-mild-and-moderate-breast-cancer-related-lymphedema-39694https://curecurrent.com/trials/contribution-of-mri-in-the-evaluation-of-apparent-diffusion-coefficient-and-prediction-of-response-to-neoadjuvant-chemot-39695https://curecurrent.com/trials/bi-2536-in-treating-patients-with-recurrent-or-metastatic-solid-tumors-39696https://curecurrent.com/trials/a-bioequivalence-study-of-capecitabine-tablets-39697https://curecurrent.com/trials/ro4929097-and-letrozole-in-treating-post-menopausal-women-with-hormone-receptor-positive-stage-ii-or-stage-iii-breast-ca-39698https://curecurrent.com/trials/premenopausal-patient-with-hormone-responsive-her2-negative-lymph-node-positive-breast-cancer-39699https://curecurrent.com/trials/akt-inhibitor-mk2206-lapatinib-ditosylate-and-trastuzumab-in-treating-patients-with-locally-advanced-or-metastatic-her2-39700https://curecurrent.com/trials/7-hydroxystaurosporine-and-irinotecan-hydrochloride-in-treating-patients-with-metastatic-or-unresectable-solid-tumors-or-39701https://curecurrent.com/trials/discordant-hormonal-status-of-breast-cancer-39702https://curecurrent.com/trials/hormone-replacement-therapy-and-the-risk-of-breast-cancer-recurrence-in-women-with-previous-early-stage-breast-cancer-39703https://curecurrent.com/trials/hypnosis-in-treating-hot-flashes-in-breast-cancer-survivors-39704https://curecurrent.com/trials/preoperative-bevacizumab-and-trastuzumab-with-abi-007-and-carboplatin-in-her2-breast-cancer-39705https://curecurrent.com/trials/surgery-with-or-without-lymph-node-removal-in-treating-older-women-with-stage-i-breast-cancer-39706https://curecurrent.com/trials/temozolomide-in-treating-women-with-advanced-breast-cancer-39707https://curecurrent.com/trials/monoclonal-antibody-therapy-cyclosporine-and-paclitaxel-in-treating-patients-with-recurrent-or-refractory-metastatic-bre-39708https://curecurrent.com/trials/biological-therapy-plus-peripheral-stem-cell-transplantation-in-treating-patients-with-advanced-breast-cancer-39709https://curecurrent.com/trials/compassionate-use-of-eribulin-for-the-treatment-of-advanced-breast-cancer-refractory-to-all-other-marketed-therapies-39710https://curecurrent.com/trials/a-phase-3-multi-center-study-of-gemcitabine-carboplatin-with-or-without-bsi-201-in-patients-with-er-pr-and-her2-negative-39711https://curecurrent.com/trials/a-study-of-ym155-plus-docetaxel-as-first-line-treatment-in-subjects-with-her2-negative-metastatic-breast-cancer-39712https://curecurrent.com/trials/omega-3-fatty-acids-in-preventing-breast-cancer-in-women-at-high-risk-of-developing-breast-cancer-39713https://curecurrent.com/trials/nutrition-intervention-in-treating-women-with-breast-cancer-39714https://curecurrent.com/trials/chemotherapy-plus-surgery-in-treating-women-with-breast-cancer-39715https://curecurrent.com/trials/discordant-her2-neu-status-of-breast-cancer-39716https://curecurrent.com/trials/exercise-program-or-health-education-program-in-reducing-fatigue-and-pain-in-breast-cancer-survivors-39717https://curecurrent.com/trials/interleukin-12-in-treating-women-with-metastatic-breast-cancer-who-have-received-high-dose-chemotherapy-and-peripheral-s-39718https://curecurrent.com/trials/an-open-label-expanded-access-protocol-of-iniparib-breast-cancer-39719https://curecurrent.com/trials/cyclosporine-a-in-combination-with-nab-paclitaxel-in-patients-with-metastatic-breast-cancer-39720https://curecurrent.com/trials/prognostic-value-of-the-marker-p63-in-adenocarcinoma-of-lung-breast-and-pancreas-39721https://curecurrent.com/trials/mek-inhibitor-pd-325901-to-treat-advanced-breast-cancer-colon-cancer-and-melanoma-39722https://curecurrent.com/trials/comparison-study-of-breast-computed-tomography-ct-with-magnetic-resonance-imaging-mri-39723https://curecurrent.com/trials/domiciliary-physiotherapy-in-women-undergoing-treatment-for-breast-cancer-radiation-39724https://curecurrent.com/trials/study-to-evaluate-markers-of-response-in-locally-advanced-breast-cancer-39725https://curecurrent.com/trials/ultrasound-and-mammography-for-screening-breast-cancer-in-chinese-women-39726https://curecurrent.com/trials/ultrasound-elastography-of-breast-lesions-39727https://curecurrent.com/trials/depocyt-with-sorafenib-in-neoplastic-meningitis-39728https://curecurrent.com/trials/regenerative-tissue-matrix-for-breast-reconstruction-39729https://curecurrent.com/trials/docetaxel-in-treating-older-women-with-metastatic-breast-cancer-39730https://curecurrent.com/trials/radiation-therapy-in-treating-older-women-who-are-undergoing-surgery-for-stage-i-or-stage-ii-breast-cancer-39731https://curecurrent.com/trials/doxorubicin-and-cyclophosphamide-in-treating-older-women-with-stage-i-stage-ii-or-stage-iii-breast-cancer-that-has-been-39732https://curecurrent.com/trials/impact-of-oncodoc2-on-guideline-compliance-in-the-management-of-breast-cancer-39733https://curecurrent.com/trials/a-phase-ib-study-of-selatinib-ditosilate-tablets-in-patients-with-advanced-breast-cancer-39734https://curecurrent.com/trials/late-cardiac-evaluation-of-the-three-arm-belgian-trial-involving-node-positive-early-breast-cancer-patients-39735https://curecurrent.com/trials/early-cardiac-toxicity-of-adjuvant-ct-in-elderly-bc-39736https://curecurrent.com/trials/prevention-of-capsular-contracture-using-trental-and-vitamin-e-39737https://curecurrent.com/trials/combination-chemotherapy-plus-filgrastim-in-treating-patients-with-advanced-solid-tumors-39738https://curecurrent.com/trials/raygel-an-alternative-for-skin-care-during-external-beam-radiation-39739https://curecurrent.com/trials/trial-of-blue-citrus-compared-to-placebo-in-patients-receiving-aromatase-inhibitor-therapy-for-estrogen-receptor-positiv-39740https://curecurrent.com/trials/scri-tissue-testing-registry-39741https://curecurrent.com/trials/fatigue-in-breast-cancer-survivors-39742https://curecurrent.com/trials/duct-endoscopy-in-assessing-cellular-atypia-in-the-breast-duct-fluid-of-women-with-a-genetic-risk-for-breast-cancer-39743https://curecurrent.com/trials/genes-and-other-risk-factors-for-second-primary-breast-cancer-in-women-with-breast-cancer-and-their-female-family-member-39744https://curecurrent.com/trials/nipple-aspiration-ductal-lavage-and-duct-endoscopy-for-diagnostic-assessment-in-women-undergoing-surgery-for-breast-canc-39745https://curecurrent.com/trials/positron-emission-tomography-computed-tomography-scanning-before-surgery-in-patients-with-non-small-cell-lung-cancer-col-39746https://curecurrent.com/trials/early-detection-of-breast-cancer-and-cervical-cancer-in-women-in-india-39747https://curecurrent.com/trials/trastuzumab-or-observation-after-combination-chemotherapy-and-trastuzumab-in-treating-patients-undergoing-surgery-for-st-39748https://curecurrent.com/trials/diet-and-exercise-or-normal-care-in-overweight-or-obese-women-who-have-undergone-treatment-for-stage-i-stage-ii-or-stage-39749https://curecurrent.com/trials/multifunctional-magnetic-resonance-imaging-in-predicting-breast-lesions-in-women-undergoing-mastectomy-for-breast-cancer-39750https://curecurrent.com/trials/fulvestrant-with-or-without-lapatinib-and-or-aromatase-inhibitor-therapy-in-treating-postmenopausal-women-with-metastati-39751https://curecurrent.com/trials/study-of-dna-mutations-in-predicting-the-effect-of-external-beam-radiation-therapy-in-patients-with-early-breast-cancer-39752https://curecurrent.com/trials/dietary-phytoestrogens-complementary-and-alternative-medicine-and-lifestyle-in-predicting-survival-of-women-with-breast-39753https://curecurrent.com/trials/acupuncture-or-self-acupuncture-in-managing-cancer-related-fatigue-in-women-who-have-received-chemotherapy-for-stage-i-s-39754https://curecurrent.com/trials/a-pilot-study-to-evaluate-nipple-areolar-complex-nac-sparing-mastectomy-39755https://curecurrent.com/trials/study-of-genes-and-environment-in-patients-with-breast-cancer-in-the-east-anglia-region-of-the-united-kingdom-39756https://curecurrent.com/trials/combination-chemotherapy-with-or-without-capecitabine-and-or-trastuzumab-before-surgery-in-treating-women-with-stage-i-s-39757https://curecurrent.com/trials/carboplatin-or-docetaxel-in-treating-women-with-metastatic-genetic-breast-cancer-39758https://curecurrent.com/trials/laser-spectroscopy-of-breast-tissue-through-a-needle-device-39759https://curecurrent.com/trials/management-of-metastatic-breast-cancer-in-clinical-practice-retrospective-study-39760https://curecurrent.com/trials/radiation-therapy-in-treating-women-with-invasive-breast-cancer-39761https://curecurrent.com/trials/trastuzumab-plus-paclitaxel-in-treating-women-with-metastatic-breast-cancer-that-overexpresses-her2-39762https://curecurrent.com/trials/mk-2206-endocrine-therapy-in-patients-with-hormone-receptor-positive-breast-cancer-39763https://curecurrent.com/trials/trial-of-mk-2206-endocrine-treatment-in-patients-with-hormone-receptor-positive-breast-cancer-39764https://curecurrent.com/trials/capecitabine-metronomic-chemotherapy-plus-aromatase-inhibitor-for-postmenopausal-hormone-receptor-positive-breast-cancer-39765https://curecurrent.com/trials/study-of-e7389-for-advanced-or-metastatic-breast-cancer-39766https://curecurrent.com/trials/self-help-treatment-for-insomnia-in-breast-cancer-patients-39767https://curecurrent.com/trials/safety-and-efficacy-of-ho-02-02-20-g-vs-soc-aloe-vera-to-reduce-radiation-dermatitis-39768https://curecurrent.com/trials/couplelinks-ca-an-online-intervention-for-couples-affected-by-breast-cancer-39769https://curecurrent.com/trials/the-involvement-of-breast-cancer-patients-during-oncological-consultations-39770https://curecurrent.com/trials/evaluation-of-chemotherapy-prior-to-surgery-with-or-without-zometa-for-women-with-locally-advanced-breast-cancer-39771https://curecurrent.com/trials/study-of-biomarkers-in-blood-and-or-tumor-tissue-samples-from-patients-with-ductal-carcinoma-in-situ-and-from-healthy-vo-39772https://curecurrent.com/trials/genetics-of-women-with-lobular-carcinoma-in-situ-of-the-breast-39773https://curecurrent.com/trials/chemotherapy-or-letrozole-before-surgery-in-treating-postmenopausal-women-with-breast-cancer-that-can-be-removed-by-surg-39774https://curecurrent.com/trials/external-beam-radiation-therapy-with-or-without-indinavir-and-ritonavir-in-treating-patients-with-brain-metastases-39775https://curecurrent.com/trials/study-of-information-received-about-fertility-and-infertility-in-patients-who-have-finished-treatment-for-cancer-39776https://curecurrent.com/trials/sunitinib-malate-and-exemestane-in-treating-postmenopausal-women-with-breast-cancer-39777https://curecurrent.com/trials/magnetic-resonance-imaging-for-the-early-detection-of-cns-metastases-in-women-with-stage-iv-breast-cancer-39778https://curecurrent.com/trials/radiation-therapy-or-standard-therapy-in-treating-women-with-stage-ii-breast-cancer-who-have-undergone-mastectomy-39779https://curecurrent.com/trials/vinflunine-plus-trastuzumab-in-human-epidermal-growth-factor-receptor-2-her2neu-over-expressing-metastatic-breast-cancer-39780https://curecurrent.com/trials/ultrasound-guided-core-biopsy-vs-fine-needle-aspiration-for-evaluation-of-axillary-lymphadenopathy-39781https://curecurrent.com/trials/trial-of-patient-navigation-activation-39782https://curecurrent.com/trials/study-to-assess-effect-of-8-wks-of-duloxetine-therapy-on-breast-cancer-patients-with-aromatase-inhibitor-associated-pain-39783https://curecurrent.com/trials/immunotherapy-after-surgery-in-treating-patients-with-breast-cancer-colon-cancer-or-melanoma-39784https://curecurrent.com/trials/vitamin-d-diet-and-activity-study-39785https://curecurrent.com/trials/mri-in-predicting-early-response-to-chemotherapy-in-patients-with-locally-advanced-breast-cancer-39786https://curecurrent.com/trials/comparison-of-four-different-treatment-regimens-in-treating-women-with-stage-i-breast-cancer-39787https://curecurrent.com/trials/filgrastim-or-pegfilgrastim-in-preventing-neutropenia-in-women-receiving-chemotherapy-following-surgery-for-breast-cance-39788https://curecurrent.com/trials/doxorubicin-or-epirubicin-and-cyclophosphamide-in-treating-older-women-with-invasive-breast-cancer-39789https://curecurrent.com/trials/monoclonal-antibody-therapy-plus-cyclosporine-and-peripheral-stem-cell-transplantation-in-treating-patients-with-metasta-39790https://curecurrent.com/trials/adjuvant-hormone-therapy-in-treating-women-with-operable-breast-cancer-39791https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-breast-cancer-who-have-undergone-surgery-39792https://curecurrent.com/trials/docetaxel-and-ifosfamide-in-treating-women-with-metastatic-breast-cancer-39793https://curecurrent.com/trials/combination-chemotherapy-and-trastuzumab-in-treating-women-with-stage-i-stage-ii-or-stage-iii-her2-positive-breast-cance-39794https://curecurrent.com/trials/chronic-pain-in-women-who-have-undergone-surgery-for-stage-i-stage-ii-or-stage-iii-breast-cancer-39795https://curecurrent.com/trials/goserelin-in-preventing-early-menopause-in-premenopausal-women-undergoing-chemotherapy-for-stage-i-stage-ii-or-stage-iii-39796https://curecurrent.com/trials/neoadjuvant-epirubicin-cyclophosphamide-and-paclitaxel-with-or-without-gemcitabine-in-treating-women-who-are-undergoing-39797https://curecurrent.com/trials/radiation-therapy-to-the-head-in-preventing-brain-metastases-in-women-receiving-trastuzumab-and-chemotherapy-for-metasta-39798https://curecurrent.com/trials/study-of-breast-cancer-shrinkage-modes-after-neoadjuvant-chemotherapy-with-whole-mount-serial-sections-and-three-dimensi-39799https://curecurrent.com/trials/genomic-grade-index-ggi-feasibility-in-routine-practice-and-impact-on-treatment-decisions-in-early-breast-cancer-39800https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-metastatic-or-recurrent-cancer-39801https://curecurrent.com/trials/the-memorial-sloan-kettering-cancer-center-mskcc-39802https://curecurrent.com/trials/cyclophosphamide-methotrexate-and-fluorouracil-with-or-without-epirubicin-hydrochloride-in-treating-women-who-have-under-39803https://curecurrent.com/trials/paclitaxel-or-docetaxel-in-treating-women-with-advanced-breast-cancer-39804https://curecurrent.com/trials/tamoxifen-citrate-in-patients-with-breast-cancer-39805https://curecurrent.com/trials/exemestane-compared-with-tamoxifen-in-treating-postmenopausal-women-with-breast-cancer-39806https://curecurrent.com/trials/computer-aided-breast-cancer-detection-in-women-undergoing-screening-mammography-39807https://curecurrent.com/trials/mitoxantrone-with-or-without-docetaxel-in-treating-women-with-metastatic-breast-cancer-39808https://curecurrent.com/trials/levofloxacin-to-prevent-infection-following-chemotherapy-in-treating-patients-with-solid-tumors-or-lymphoma-39809https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-stage-iii-breast-cancer-39810https://curecurrent.com/trials/chemotherapy-and-or-hormone-therapy-with-or-without-zoledronate-in-treating-women-with-stage-ii-or-stage-iii-breast-canc-39811https://curecurrent.com/trials/chemotherapeutic-agents-in-brain-breast-39812https://curecurrent.com/trials/pyridoxine-in-preventing-hand-foot-syndrome-in-patients-who-are-receiving-capecitabine-for-advanced-colorectal-cancer-or-39813https://curecurrent.com/trials/tamoxifen-ovarian-ablation-and-or-chemotherapy-in-treating-women-with-stage-i-stage-ii-or-stage-iiia-breast-cancer-39814https://curecurrent.com/trials/role-of-3d-tomography-in-breast-cancer-39815https://curecurrent.com/trials/phase1b-to-evaluate-safety-of-amg706-in-combination-with-paclitaxel-or-docetaxel-for-breast-cancer-39816https://curecurrent.com/trials/doxorubicin-hci-liposome-injection-versus-weekly-docetaxel-in-patients-first-relapse-metastatic-breast-cancer-39817https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-bevacizumab-in-combination-with-chemotherapy-in-previously-treated-metast-39818https://curecurrent.com/trials/capecitabine-and-pseudomonas-aeruginosa-combination-in-metastatic-breast-cancer-mbc-39819https://curecurrent.com/trials/hypercoagulability-after-breast-cancer-surgery-39820https://curecurrent.com/trials/il-6-and-il-8-level-of-blood-and-pleural-effusion-during-chemotherapy-in-metastatic-breast-cancer-39821https://curecurrent.com/trials/transformation-potential-of-e2-exposed-breast-cancer-susceptibility-gene-mutation-heterozygous-epithelial-breast-cells-39822https://curecurrent.com/trials/a-prospective-assessment-of-loss-of-grip-strength-by-baseline-bmi-in-breast-cancer-patients-receiving-adjuvant-aromatase-39823https://curecurrent.com/trials/evaluation-of-predictive-factors-regarding-the-effectivity-of-aromatase-inhibitor-therapy-preface-39824https://curecurrent.com/trials/percutaneous-removal-and-margin-ablation-for-breast-cancer-39825https://curecurrent.com/trials/effect-of-yoga-in-reducing-chemotherapy-induced-nausea-and-vomiting-39826https://curecurrent.com/trials/sequential-high-dose-chemotherapy-and-stem-cell-transplantation-in-treating-patients-with-chemotherapy-sensitive-metasta-39827https://curecurrent.com/trials/triple-negative-breast-cancer-biomarker-study-39828https://curecurrent.com/trials/safety-and-efficacy-study-of-alt-801-to-treat-progressive-metastatic-malignancies-39829https://curecurrent.com/trials/a-trial-of-paclitaxel-and-bevacizumab-vs-gemcitabine-paclitaxel-and-bevacizumab-in-advanced-breast-cancer-39830https://curecurrent.com/trials/combination-chemotherapy-with-or-without-trastuzumab-in-treating-women-with-breast-cancer-39831https://curecurrent.com/trials/radiation-therapy-in-treating-women-with-stage-i-or-stage-ii-breast-cancer-39832https://curecurrent.com/trials/intravenous-interleukin-4-pe38kdel-cytotoxin-in-treating-patients-with-recurrent-or-metastatic-kidney-cancer-non-small-c-39833https://curecurrent.com/trials/epoetin-alfa-in-treating-chemotherapy-related-anemia-in-women-with-stage-i-stage-ii-or-stage-iii-breast-cancer-39834https://curecurrent.com/trials/s0430-cyclophosphamide-and-capecitabine-in-treating-women-with-stage-iv-breast-cancer-39835https://curecurrent.com/trials/phase-ii-dasatinib-study-in-advanced-breast-cancer-39836https://curecurrent.com/trials/epidemiology-study-in-postmenopausal-women-with-estrogen-receptor-positive-breast-cancer-39837https://curecurrent.com/trials/a-phase-ii-safety-and-tolerability-study-of-bevacizumab-when-added-to-single-agent-chemotherapy-to-treat-patient-with-br-39838https://curecurrent.com/trials/effects-of-electrical-stimulation-on-blood-circulation-and-sensibility-tactil-in-lymphadenectomy-39839https://curecurrent.com/trials/feasibility-of-a-supportive-education-program-for-latina-breast-cancer-survivors-39840https://curecurrent.com/trials/study-of-apn201-liposomal-recombinant-human-cu-zn-superoxide-dismutase-for-the-prevention-of-radiation-induced-dermatiti-39841https://curecurrent.com/trials/accelerated-partial-breast-radiotherapy-with-either-mammosite-or-intensity-modulated-radiotherapy-39842https://curecurrent.com/trials/comparison-of-biomarkers-based-on-fine-needle-aspiration-in-women-at-increased-or-normal-risk-of-breast-cancer-39843https://curecurrent.com/trials/fluorescein-for-sentinel-lymph-node-biopsy-slnb-in-breast-cancer-39844https://curecurrent.com/trials/effect-of-lifestyle-factors-and-hormone-function-on-breast-density-in-healthy-hispanic-women-who-are-undergoing-mammogra-39845https://curecurrent.com/trials/methotrexate-with-or-without-antineoplaston-therapy-in-treating-postmenopausal-women-with-advanced-refractory-breast-can-39846https://curecurrent.com/trials/neoadjuvant-and-adjuvant-exemestane-in-treating-postmenopausal-women-with-locally-advanced-hormone-receptor-positive-bre-39847https://curecurrent.com/trials/cyclophosphamide-plus-vaccine-therapy-in-treating-patients-with-advanced-cancer-39848https://curecurrent.com/trials/biomarkers-in-predicting-response-to-tamoxifen-and-letrozole-in-postmenopausal-women-with-primary-breast-cancer-treated-39849https://curecurrent.com/trials/exemestane-with-or-without-atn-224-in-treating-postmenopausal-women-with-recurrent-or-advanced-breast-cancer-39850https://curecurrent.com/trials/psychological-and-emotional-impact-in-patients-undergoing-treatment-for-metastatic-cancer-either-in-a-clinical-trial-or-39851https://curecurrent.com/trials/stress-reduction-in-older-women-with-stage-ii-stage-iii-or-stage-iv-breast-cancer-39852https://curecurrent.com/trials/combination-chemotherapy-followed-by-peripheral-stem-cell-transplantation-in-treating-patients-with-advanced-breast-canc-39853https://curecurrent.com/trials/real-world-efficiency-of-trastuzumab-in-early-breast-cancer-39854https://curecurrent.com/trials/antineoplaston-therapy-in-treating-women-with-advanced-breast-cancer-39855https://curecurrent.com/trials/trastuzumab-and-capecitabine-in-treating-women-with-metastatic-breast-cancer-39856https://curecurrent.com/trials/blood-sample-collection-and-health-information-collection-from-patients-with-invasive-breast-cancer-and-their-brothers-a-39857https://curecurrent.com/trials/studying-changes-in-breast-density-in-patients-with-early-stage-breast-cancer-treated-with-metformin-hydrochloride-or-pl-39858https://curecurrent.com/trials/lapatinib-with-trastuzumab-in-treating-patients-with-her2-negative-her2-mutant-metastatic-breast-cancer-39859https://curecurrent.com/trials/testing-of-different-methods-for-determining-whether-breast-cancer-has-spread-to-the-lymph-nodes-39860https://curecurrent.com/trials/chemotherapy-in-treating-patients-with-solid-tumors-39861https://curecurrent.com/trials/raloxifene-and-goserelin-in-preventing-breast-cancer-in-women-with-a-family-history-of-breast-cancer-39862https://curecurrent.com/trials/radiation-therapy-planning-techniques-in-reducing-damage-to-normal-tissue-in-women-undergoing-breast-conserving-surgery-39863https://curecurrent.com/trials/gemcitabine-in-treating-women-with-metastatic-breast-cancer-previously-treated-with-doxorubicin-and-paclitaxel-39864https://curecurrent.com/trials/triptorelin-in-preventing-early-menopause-in-premenopausal-women-who-are-receiving-chemotherapy-for-stage-i-stage-ii-or-39865https://curecurrent.com/trials/monoclonal-antibody-huhmfg1-in-treating-women-with-locally-advanced-or-metastatic-breast-cancer-39866https://curecurrent.com/trials/chemotherapy-in-treating-patients-with-refractory-advanced-solid-tumors-or-hematologic-cancer-39867https://curecurrent.com/trials/vinorelbine-with-or-without-trastuzumab-in-treating-women-with-progressive-metastatic-breast-cancer-39868https://curecurrent.com/trials/hormone-therapy-in-treating-women-with-breast-cancer-39869https://curecurrent.com/trials/paclitaxel-plus-monoclonal-antibody-therapy-in-treating-women-with-recurrent-or-metastatic-breast-cancer-39870https://curecurrent.com/trials/simvastatin-and-anastrozole-in-treating-postmenopausal-women-with-ductal-carcinoma-in-situ-or-invasive-breast-cancer-39871https://curecurrent.com/trials/pilot-study-comparing-hypnotherapy-and-gabapentin-for-hot-flashes-39872https://curecurrent.com/trials/a-study-to-determine-the-clinical-significance-of-molecular-detection-of-breast-cancer-in-the-blood-of-stage-iv-breast-c-39873https://curecurrent.com/trials/octreotide-tamoxifen-and-chemotherapy-in-treating-women-with-breast-cancer-39874https://curecurrent.com/trials/vaccine-therapy-plus-interleukin-2-in-treating-women-with-stage-iv-recurrent-or-progressive-breast-or-ovarian-cancer-39875https://curecurrent.com/trials/ixabepilone-in-treating-patients-with-locally-advanced-or-metastatic-breast-cancer-39876https://curecurrent.com/trials/vaccine-therapy-and-biological-therapy-in-treating-patients-with-advanced-cancer-39877https://curecurrent.com/trials/allogeneic-peripheral-stem-cell-transplantation-in-treating-patients-with-stage-iv-breast-cancer-39878https://curecurrent.com/trials/raloxifene-in-preventing-breast-cancer-in-premenopausal-women-39879https://curecurrent.com/trials/lovastatin-in-reducing-side-effects-after-radiation-therapy-in-women-with-breast-cancer-39880https://curecurrent.com/trials/docetaxel-plus-garlic-in-treating-patients-with-locally-advanced-or-metastatic-breast-cancer-39881https://curecurrent.com/trials/azd2171-and-combination-chemotherapy-in-treating-women-with-locally-advanced-breast-cancer-39882https://curecurrent.com/trials/gemcitabine-combined-with-mistletoe-in-treating-patients-with-advanced-solid-tumors-39883https://curecurrent.com/trials/liposomal-doxorubicin-and-trastuzumab-in-treating-women-with-locally-advanced-inflammatory-or-metastatic-breast-cancer-39884https://curecurrent.com/trials/study-of-cancer-peptides-vaccine-plus-gm-csf-as-adjuvant-treatment-for-high-risk-txn2-3m0-or-metastatic-breast-cancer-wi-39885https://curecurrent.com/trials/erlotinib-in-treating-patients-with-locally-advanced-or-metastatic-breast-cancer-39886https://curecurrent.com/trials/paclitaxel-doxorubicin-and-cyclophosphamide-with-or-without-carboplatin-in-treating-women-with-locally-advanced-breast-c-39887https://curecurrent.com/trials/tipifarnib-plus-tamoxifen-in-treating-women-with-metastatic-breast-cancer-39888https://curecurrent.com/trials/efficacy-and-safety-of-bevacizumab-in-the-neodjuvant-treatment-of-inflammatory-breast-cancer-39889https://curecurrent.com/trials/cone-beam-ct-for-breast-imaging-39890https://curecurrent.com/trials/vaccine-therapy-plus-sargramostim-and-chemotherapy-in-treating-women-with-stage-ii-or-stage-iii-breast-cancer-39891https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-stage-i-breast-cancer-39892https://curecurrent.com/trials/bms-247550-in-treating-women-with-metastatic-breast-cancer-39893https://curecurrent.com/trials/cone-beam-computed-tomography-for-breast-imaging-39894https://curecurrent.com/trials/trial-of-lymphoseek-in-intraoperative-localization-of-lymph-nodes-in-breast-cancer-and-melanoma-39895https://curecurrent.com/trials/safety-study-for-short-course-accelerated-hypofractionated-partial-breast-radiotherapy-apbi-in-women-with-early-stage-br-39896https://curecurrent.com/trials/docetaxel-and-flavopiridol-in-treating-patients-with-locally-advanced-or-metastatic-breast-cancer-39897https://curecurrent.com/trials/breast-and-melanoma-trial-with-lymphoseek-to-identify-lymph-nodes-39898https://curecurrent.com/trials/phase-ii-bevacizumab-tax-in-advanced-breast-cancer-39899https://curecurrent.com/trials/trial-of-neoadjuvant-endotag-1-in-combination-with-paclitaxel-in-her2-negative-breast-cancer-39900https://curecurrent.com/trials/using-the-conture-multi-lumen-balloon-to-deliver-accelerated-partial-breast-brachytherapy-39901https://curecurrent.com/trials/pilot-clinical-trial-phase-ii-of-inquiry-based-stress-reduction-ibsr-program-for-survivors-of-breast-cancer-39902https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-herceptin-trastuzumab-in-combination-with-arimidex-anastrozole-an-aromata-39903https://curecurrent.com/trials/incidence-of-blood-clots-in-patients-undergoing-chemotherapy-for-solid-tumors-39904https://curecurrent.com/trials/lapatinib-in-treating-brain-metastases-in-patients-with-stage-iv-breast-cancer-and-brain-metastases-39905https://curecurrent.com/trials/s0215-trastuzumab-docetaxel-vinorelbine-and-filgrastim-in-treating-women-with-stage-iv-breast-cancer-39906https://curecurrent.com/trials/long-term-follow-up-of-persistent-pain-sensory-disturbances-and-lymphedema-after-breast-cancer-treatment-39907https://curecurrent.com/trials/tipifarnib-doxorubicin-and-cyclophosphamide-in-treating-women-with-locally-advanced-breast-cancer-39908https://curecurrent.com/trials/safety-study-in-subjects-with-metastatic-breast-cancer-who-progressed-after-taxanes-treatment-39909https://curecurrent.com/trials/a-study-comparing-ex-vivo-mri-versus-radiography-of-breast-specimens-39910https://curecurrent.com/trials/paclitaxel-with-or-without-trastuzumab-in-treating-patients-with-or-without-her-2-neu-breast-cancer-that-is-inoperable-r-39911https://curecurrent.com/trials/interleukin-12-paclitaxel-and-trastuzumab-in-treating-patients-with-solid-tumors-39912https://curecurrent.com/trials/bevacizumab-and-docetaxel-in-treating-women-with-locally-advanced-or-metastatic-breast-cancer-39913https://curecurrent.com/trials/tamoxifen-pharmacogenetics-in-asian-breast-cancer-women-39914https://curecurrent.com/trials/chemotherapy-plus-monoclonal-antibody-therapy-in-treating-women-with-stage-ii-or-stage-iiia-breast-cancer-that-overexpre-39915https://curecurrent.com/trials/male-breast-cancer-summa-health-system-akron-city-hospital-experience-1995-2007-39916https://curecurrent.com/trials/effect-of-the-nursing-intervention-spiritual-support-39917https://curecurrent.com/trials/development-of-a-clinical-trial-specific-question-prompt-list-39918https://curecurrent.com/trials/combination-chemotherapy-and-peripheral-stem-cell-transplantation-in-treating-women-with-metastatic-breast-cancer-39919https://curecurrent.com/trials/amonafide-in-treating-women-with-metastatic-breast-cancer-that-has-progressed-after-previous-chemotherapy-39920https://curecurrent.com/trials/bryostatin-1-in-treating-patients-with-stage-iv-breast-cancer-39921https://curecurrent.com/trials/genesearch-breast-lymph-node-bln-assay-china-registration-study-39922https://curecurrent.com/trials/metformin-and-temsirolimus-in-treating-patients-with-metastatic-or-unresectable-solid-tumor-or-lymphoma-39923https://curecurrent.com/trials/bexarotene-in-treating-patients-with-metastatic-breast-cancer-39924https://curecurrent.com/trials/chemotherapy-combined-with-gene-therapy-in-treating-patients-who-have-stage-iii-or-stage-iv-breast-cancer-39925https://curecurrent.com/trials/psychosocial-support-in-treating-women-with-recurrent-breast-cancer-or-stage-i-stage-ii-or-stage-iv-breast-cancer-39926https://curecurrent.com/trials/chemotherapy-plus-peripheral-stem-cell-transplantation-in-treating-women-with-metastatic-breast-cancer-39927https://curecurrent.com/trials/suberoylanilide-hydroxamic-acid-in-treating-patients-with-advanced-cancer-39928https://curecurrent.com/trials/s8814a-biomarkers-in-predicting-outcome-in-postmenopausal-women-with-hormone-receptor-positive-node-positive-breast-canc-39929https://curecurrent.com/trials/breast-cancer-lymphedema-role-of-insulin-resistance-foxc2-39930https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-breast-cancer-39931https://curecurrent.com/trials/cryosurgery-in-treating-women-with-breast-lesions-39932https://curecurrent.com/trials/will-preoperative-mri-breast-in-women-under-56-years-with-breast-cancer-change-primary-treatment-39933https://curecurrent.com/trials/study-to-evaluate-the-safety-and-effects-azd0530-on-prostate-and-breast-cancer-subjects-with-metastatic-bone-disease-39934https://curecurrent.com/trials/corrected-qt-interval-effects-of-trastuzumab-emtansine-t-dm1-in-patients-with-human-epidermal-growth-factor-receptor-2-h-39935https://curecurrent.com/trials/study-of-sunitinib-with-capecitabine-in-breast-cancer-39936https://curecurrent.com/trials/effect-of-aromatase-inhibitors-on-bones-and-genes-39937https://curecurrent.com/trials/phase-2-endocrine-therapy-osi-906-with-or-without-erlotinib-for-hormone-sensitive-metastatic-breast-cancer-39938https://curecurrent.com/trials/internet-support-for-cancer-patients-39939https://curecurrent.com/trials/nab-paclitaxel-in-metastatic-breast-cancer-patients-failing-solvent-based-taxane-tiffany-39940https://curecurrent.com/trials/a-randomized-study-to-determine-the-efficacy-of-a-taxane-and-bevacizumab-with-or-without-capecitabine-as-first-line-chem-39941https://curecurrent.com/trials/a-mammography-fasttrack-program-in-increasing-the-number-of-women-undergoing-breast-cancer-screening-39942https://curecurrent.com/trials/genistein-in-preventing-breast-or-endometrial-cancer-in-healthy-postmenopausal-women-39943https://curecurrent.com/trials/ex-vivo-expanded-her2-specific-t-cells-and-cyclophosphamide-after-vaccine-therapy-in-treating-patients-with-her2-positiv-39944https://curecurrent.com/trials/evaluating-an-internet-based-intervention-for-insomnia-in-breast-cancer-survivors-39945https://curecurrent.com/trials/comparison-study-of-sentinel-lymph-node-biopsy-by-multimodal-method-in-breast-cancer-39946https://curecurrent.com/trials/a-study-of-vorinostat-and-tamoxifen-in-newly-diagnosed-breast-cancer-39947https://curecurrent.com/trials/technetium-tc-99m-sulfur-colloid-and-blue-dye-in-detecting-sentinel-lymph-nodes-in-patients-with-breast-cancer-39948https://curecurrent.com/trials/radiolabeled-monoclonal-antibody-therapy-followed-by-bone-marrow-or-peripheral-stem-cell-transplantation-in-treating-pat-39949https://curecurrent.com/trials/timing-of-menstrual-cycle-and-surgery-in-treating-premenopausal-women-with-stage-i-stage-ii-or-stage-iii-breast-cancer-39950https://curecurrent.com/trials/monoclonal-antibody-compared-with-zoledronate-in-treating-women-with-breast-cancer-and-bone-metastases-39951https://curecurrent.com/trials/chronic-graft-versus-host-disease-in-patients-who-have-undergone-donor-stem-cell-transplant-39952https://curecurrent.com/trials/a-study-of-zyc300-administered-with-cyclophosphamide-pre-dosing-39953https://curecurrent.com/trials/89zr-trastuzumab-pet-for-imaging-the-effect-of-hsp90-inhibition-39954https://curecurrent.com/trials/magnetic-resonance-imaging-of-lymph-nodes-using-ferumoxytol-in-patients-with-primary-prostate-or-breast-cancer-39955https://curecurrent.com/trials/efficacy-and-safety-of-dlbs1425-as-neoadjuvant-in-stage-ii-or-iii-breast-cancer-patients-39956https://curecurrent.com/trials/a-study-of-carboplatin-paclitaxel-with-pegfilgrastim-supported-by-haematopoietic-progenitor-cell-re-infusion-in-whole-bl-39957https://curecurrent.com/trials/bevacizumab-in-combination-with-vinorelbine-and-trastuzumab-for-her2-positive-metastatic-breast-cancer-39958https://curecurrent.com/trials/relaxation-and-visualization-therapy-for-breast-cancer-patients-39959https://curecurrent.com/trials/a-study-to-assess-capecitabine-xeloda-in-patients-with-locally-advanced-or-metastatic-breast-cancer-39960https://curecurrent.com/trials/the-use-of-molecular-breast-imaging-in-the-evaluation-of-tumor-response-to-neoadjuvant-therapy-in-women-with-breast-canc-39961https://curecurrent.com/trials/whole-brain-radiation-therapy-with-oxygen-with-or-without-rsr13-in-women-with-brain-metastases-from-breast-cancer-39962https://curecurrent.com/trials/letrozole-and-goserelin-or-leuprolide-in-treating-premenopausal-estrogen-receptor-positive-patients-with-stage-iv-breast-39963https://curecurrent.com/trials/high-dose-chemotherapy-total-body-irradiation-and-autologous-stem-cell-transplantation-or-bone-marrow-transplantation-in-39964https://curecurrent.com/trials/pegfilgrastim-as-support-to-advanced-breast-cancer-patients-receiving-chemotherapy-39965https://curecurrent.com/trials/drug-withdrawal-in-women-with-progressive-breast-cancer-while-on-aromatase-inhibitor-therapy-39966https://curecurrent.com/trials/neoadjuvant-ecs-versus-ecf-in-local-advanced-breast-cancer-39967https://curecurrent.com/trials/randomized-trial-on-intraoperative-radiotherapy-full-dose-vs-external-radiotherapy-39968https://curecurrent.com/trials/ptk-and-letrozole-in-post-menopausal-women-with-advanced-breast-cancer-39969https://curecurrent.com/trials/distinction-between-lung-cancer-and-gynecological-cancers-by-canine-scent-detection-39970https://curecurrent.com/trials/paclitaxol-every-2-week-versus-paclitaxol-every-1-week-in-the-adjuvant-treatment-of-breast-cancer-39971https://curecurrent.com/trials/safety-assessment-of-lactobacillus-fermented-extract-in-cancer-patients-undergoing-chemotherapy-39972https://curecurrent.com/trials/study-of-tamoxifen-dose-escalation-in-breast-cancer-patients-with-cyp2d6-polymorphisms-39973https://curecurrent.com/trials/sulindac-in-preventing-breast-cancer-in-women-at-high-risk-for-breast-cancer-39974https://curecurrent.com/trials/diffuse-optical-tomography-dot-for-monitoring-response-to-neoadjuvant-preoperative-chemotherapy-in-breast-cancer-39975https://curecurrent.com/trials/mycophenolate-mofetil-mmf-for-treatment-of-chronic-graft-versus-host-disease-gvhd-39976https://curecurrent.com/trials/yttrium-y-90-smt-487-in-treating-patients-with-refractory-or-recurrent-cancer-39977https://curecurrent.com/trials/radiolabeled-smt-487-yttrium-y-90-dota-tyr3-octreotide-in-treating-patients-with-refractory-small-cell-lung-cancer-or-me-39978https://curecurrent.com/trials/riluzole-in-women-with-stage-i-stage-ii-or-stage-iiia-breast-cancer-39979https://curecurrent.com/trials/weight-loss-counseling-for-african-american-women-who-are-breast-cancer-survivors-39980https://curecurrent.com/trials/phase-i-ii-study-of-escalating-dose-melphalan-w-autologous-scs-amifostine-cytoprotect-39981https://curecurrent.com/trials/individualized-risk-based-education-in-promoting-breast-cancer-screening-in-healthy-women-39982https://curecurrent.com/trials/gpx-100-in-treating-patients-with-solid-tumors-39983https://curecurrent.com/trials/a-study-of-e7389-in-advanced-metastatic-breast-cancer-patients-39984https://curecurrent.com/trials/docetaxel-based-anthracycline-free-adjuvant-treatment-evaluation-as-well-as-life-style-intervention-39985https://curecurrent.com/trials/exploratory-study-of-norepinephrine-to-prevent-radiodermatitis-in-breast-cancer-patients-39986https://curecurrent.com/trials/treatment-decision-impact-of-oncotypedx-in-hr-n-breast-cancer-patients-39987https://curecurrent.com/trials/crrs-4-pivotal-somo-v-abus-roc-reader-observer-study-39988https://curecurrent.com/trials/exploratory-study-of-breast-cancer-with-aby025-39989https://curecurrent.com/trials/ci-1040-in-treating-patients-with-advanced-breast-colon-pancreatic-or-non-small-cell-lung-cancer-39990https://curecurrent.com/trials/growth-factor-levels-in-the-blood-of-patients-undergoing-radiation-therapy-for-epithelial-cancer-39991https://curecurrent.com/trials/cancer-genetics-cd-rom-for-hispanics-39992https://curecurrent.com/trials/an-online-psychoeducational-intervention-for-young-women-with-breast-cancer-and-their-partners-39993https://curecurrent.com/trials/s0307a-long-term-bone-quality-in-women-with-breast-cancer-enrolled-on-clinical-trial-swog-s0307-39994https://curecurrent.com/trials/purged-circulating-tumor-cells-ctcs-from-metastatic-breast-cancer-39995https://curecurrent.com/trials/alvespimycin-hydrochloride-in-treating-patients-with-metastatic-or-unresectable-solid-tumors-39996https://curecurrent.com/trials/preoperative-herceptin-navelbine-versus-taxotere-carboplatin-herceptin-in-her-2-positive-breast-cancer-39997https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-stage-iii-or-stage-iv-breast-cancer-39998https://curecurrent.com/trials/skin-biopsies-and-dna-analysis-in-patients-receiving-irinotecan-or-gemcitabine-for-advanced-solid-tumors-39999https://curecurrent.com/trials/high-dose-combination-chemotherapy-plus-peripheral-stem-cell-transplantation-compared-with-standard-combination-chemothe-40000